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Abstracts of papers presented at the ISLAR
(International Symposium on Laboratory
Automation and Robotics) 1996
The fourteenth International Symposium on Laboratory Automation and Robotics was held from 20-23 October 1996
in Boston, MA, USA, and proved the largest number of technical presentations ever offered at this meeting. State-of-the
art developments in laboratory automation and robotics were reflected in the symposium programme, including papers
and posters on all aspects of the technology--drug discovery research, data handling and data management, chemical
analysis, custom automation, laboratory workstations, bioanalytical assays, managing laboratory automation, dissolu-
tion testing, pharmaceutical analysis, automation and combinatorial chemistry, validating automated methods, and
advanced topics. Several new workshops and discussion sessions were also provided.
Zymark should be congratulated on their continuing commitment to this programme of seminars and technical sessions.
The programme provided a valuable insight to the use of robotics as well as the problems experienced. We hope to
include some of these articles as technical papers in the journal in the near future.
The 1997 ISLAR will once again be held in Boston, MA, from 19-22 October 1997. Speakers’ abstracts should be
submitted by 14 March and Poster abstracts by 14 July. Session topics will be similar to previous years but will also
include High Throughput Screening, Re-Engineering the Laboratory and Increasing Productivity. For more
information, contact Christine O’Neil at 508497 2224; fax on 508435 3439; send an E-mail to islar@ISLAR.com or
visit the ISLAR pages at http://www.islar.com.
Drug discovery meets biotech: how automation
enables the ’better-faster-cheaper’ paradigm
Walter H. Moos
Chiton Corporation, Emeryville, CA, USA
Pharmaceutical and biotechnology companies have faced
significant new challenges in the 1990s. Health care cost-
containment, mergers and acquisitions, venture-capital
funded technology development, and other forces have
catalysed important paradigm shifts in therapeutic re-
search and development. The resulting efforts to per-
form drug discovery and preclinical development better,
faster, and cheaper, are being aided by new approaches
in the design, synthesis, screening, and optimization of
product candidates. Core competencies in automation
underpin a major portion of this new wave of unprece-
dented productivity. Several examples of Chiron’s cluster
of combinatorial technologies were discussed.
The strategic direction of bioanalytical support
for drug development
James E. McClurg
Harris Life Science, Lincoln, NE, USA
The types and volume of bioanalytical support of drug
development being outsourced by pharmaceutical com-
panies is changing rapidly. There are a number of forces
causing this change: bioanalytical technology, cost and
time pressures, the proportion ofdrug development being
done by ’start-up’ ventures, compliance issues, geo-
graphic locations, sample logistics, clinical study designs,
types of therapeutic molecules, competition, use of tox-
icokinetic data to design early clinical trials, etc.
These issues and the roles they play in painting the
opportunities/challenges picture of outsourced bioanaly-
tical support for drug development on the five yea.r
horizon were discussed.
The automated synthesis of organic compounds
some newcomers have some success
Christopher Floyd, Christopher Lewis,
Patel and Mark Whittaker
British Biotech Pharmaceuticals Ltd, Oxford, UK
Sanjay
The search for useful drug substances is accelerating. The
increasing speed and reliability ofautomated assays using
microtitre plates has led to a situation where traditional
one-by-one organic synthesis can no longer keep up, and
automated devices are required for organic synthesis,
purification, and distribution for assay. By deliberately
avoiding over-automation the authors have a flexible
system in which the devices can be used in the most
appropriate way, as different therapeutic project areas
have different, and changing, needs. In particular they
work at a scale that provides enough material for follow-
up in vivo testing, as well as initial screening.
A key part of the system is a Zymark XP Zymate
laboratory robot. It is equipped with custom-built work
stations to enable it to cleave small molecules into
solution after solid phase synthesis, to evaporate the
acidic solutions to near dryness, and to dilute, dissolve
and distribute into 96-well plates. All of these functions
may be used independently, or chained together for a
complete processing run. A MultiSyn Tech Syro I is used
for the solid phase syntheses and a Gilson Preparative
HPLC using an Aspec XL as an autoinjector and fraction
collector is used for purification, if required.
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The presentation described the synthesis and subsequent
treatment of some sulphonamides and small peptides,
demonstrating how some of the disparate needs of the
different projects were met.
Acclerating drug discovery by high-throughput
combinatorial synthesis
Steven C. Banville and Ronald N. Zuckermann
Chiton Corporation, Emeryville, CA, USA
A fully automated organic synthesizer has been con-
structed to generate diverse chemical libraries for use in
drug screening programmes. This high-throughput
chemical synthesizer is based on proprietary robotic
synthesis hardware and software. The robotic synthesizer
is able to transform a small set of low-cost starting
materials into an equimolar mixture of tens of thousands
of novel diverse chemical structures. These mixtures can
then be screened against a wide variety of pharmaceuti-
cally relevant receptors. Reptoids (N-substituted gly-
cines), as well as peptides, can be synthesized in very
high yields. Peptoids have the added advantage that they
can be synthesized from an incredibly large pool of
commercially available primary amines. Highly potent
peptoid trimers have been discovered with this technol-
ogy. More complex chemical structures are also being
made; this has prompted significant design changes in the
synthesis hardware. Recently, a new generation synthe-
sizer has been constructed that features a high tempera-
ture heat block as well as more flexible software. This
automated system has thus evolved from peptide synthe-
sizer into a more general purpose organic synthesizer.
Automated organic chemical synthesis at
Organon
P. Hilberink, S. v. Aelst, F. Kaspersen
Scientific Development Group, N.V. Organon, The Netherlands
T. Vink
E/I/A Automation, N.V. Diosynth, The Netherlands
and E. v. Gool
Labotec SA/NV, Teralfene, Belgium
This presentation described Organon’s synthesis robot
which is used for reaction optimization for the synthesis of
biologically active compounds. Some results of the ex-
periments performed with this system were also pre-
sented. The automated synthesis system is centred
around a Zymark XP-robot. With the use of a number
of working stations (vortex; capping-station, cleaning
station, solvents-station, balance), storage racks for re-
agents/samples and four different robot-hands, the sys-
tem is capable of performing (this means starting, actual
chemical reaction, sampling, partial work up and clean-
ing) automatically a great variety of organic reactions in
two reaction vessels. The reaction vessels have a working
volume of25-125 ml (so experiments on preparative scale
can be done), the temperature can be varied from -40C
to 140C (reflux is possible) in either N2 or Ar-atmos-
phere with controlled stirring. The system is set up in a
vented hood and the power supply is backed up by a
battery pack. Control of the robot and the reaction
vessels is separated by the use of two System V con-
trollers. In case of a robotic error, it is always possible to
control the reaction vessels. Programming is through a
software program developed in house, running on a
standard 486 computer. The recipes for reactions are
constructed from unit operations where variables like
temperature, reaction time can be introduced.
The automated synthesis system has been operational
since January 1995. Since then some 250 reactions have
been done successfully; some typical examples in the field
of steroid/carbohydrate/heterocyclic chemistry were
shown. From these experiments some drawbacks of the
synthesis system could be identified; improvements that
will be/have been introduced, were discussed.
Adaptation of liquid handlers to the automation of
organic and combinatorial chemistry
William Neil, Harold N. Weller, Michael Lawrence
and Marian G. Young
The Bristol-Myers Squibb Pharmaceutical Research Institute,
Princeton, NJ, USA
High throughput screening has been at the forefront of
laboratory automation for several years, resulting in
rapid and efficient biological testing. Recent efforts have
focused on automating the synthesis of new candidate
molecules for screening, particularly through the use of
combinatorial methods. Traditional robotic liquid hand-
lers have been designed for delivery of aqueous samples
for biological assays, and are not necessarily suitable for
delivery of organic solvents and solutes. Additionally,
screening applications are often run by a dedicated
operator or team of operators, while apparatus for
combinatorial organic synthesis may be used by a large
and heterogeneous group often located at more than one
site. Several of the problems and solutions related to
conversion of conventional robotic liquid handlers to
use in organic synthesis were discussed.
The Hamilton Microlab 2200 liquid handler is used by
the authors to perform many liquid handling tasks,
including product distribution, and reagent delivery for
both solution and solid phase chemistry. Many hardware
and software modifications have been incorporated into
the system to adequately support the needs of organic
and combinatorial chemistry. By using a universal deck
layout and common carriers identical systems can be
provided at several sites. The methods are not specific to
the Hamilton Microlab, and application to other liquid
handlers was discussed.
Managing laboratory automation--historical ret-
rospective and future view
Keith D. Holmes
Pfizer Inc., Groton, CT, USA
A retrospective view of automation and management
from the late 1970s until today shows that industry and
instrument companies have made tremendous strides in
automation. However, the management of laboratory
automation in future will probably be dramatically
different from today’s management. The ’virtual labora-
tory’ may be a real possibility and rapid chemical screen-
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ing of hundreds of compounds a month may be common-
place. The relationship between industry and academia
(at all levels) will become much more collaborative. In
this presentation, the author discussed the preparations
that might be made to meet these challenges.
Relocating and re-establishing a robotics labora-
tory
Stephen Scypinski, Theodore Sadlowski and
John Baiano
Hoffmann-La Roche Inc., Nutley, dV, USA
Over the past several years, there have been many
presentations at various ISLAR meetings devoted to
the trials and tribulations of establishing a robotics
facility in an existing laboratory environment. The
considerations necessary to properly fit out such a
laboratory have been discussed. Recently, the Analytical
R&D Department at Hoffmann-La Roche has had the
good fortune (or painful task) or moving out of an
existing laboratory into a newly constructed building.
The new laboratory was specifically designed to accom-
modate robotic systems and was not ’converted’ from a
laboratory already in use. This allowed the greatest
efficiency in the use of space and in design of services
needed for the systems. It was also a learning experience,
with regard to areas such as building, utility and
municipal codes. The room was even fitted with its own
high-pressure hot water system to supply the cleaning
stations on the robots.
Once the laboratory had been completed and a certifi-
cate of occupancy was obtained, the robotic systems had
to be moved. The monumental task of disassembling,
packing, moving and then reassembling three Py systems,
as well as the various workstations along with their
supporting instrumentation (HPLC pumps and detec-
tors), took several months to completely accomplish.
After reinstallation, the process of revalidation was
undertaken.
This presentation offered tips and information to anyone
faced with, or contemplating, moving their robotic
systems to a new location.
Laboratory automation--successful approach
Myriam L. Martinez
McNeil Consumer Products, Las Piedras, PR, USA
McNeil Consumer Products (PR) Inc. is a manufactur-
ing site for solid dosages of Tylenol (all adult products),
Children Chewables, Tylenol PM and Tylenol Sinus.
The Analytical Laboratory is under quality assurance
and is responsible for the release of all products after
testing. An important factor is that it works in a ’just in
time’ environment, where the releases have to be done
immediately to have the product always available in the
market. The initial approaches for the acquisition of
automated systems were to release Tylenol PM products
as quickly as possible without adding headcount. When
the new equipment was installed and running the follow-
ing resulted.
(1)
(2)
(4)
(5)
(6)
Automation allowed the product to be released in
less time, considerably reducing the lead time of
products.
Reduction of investigations due to human errors and
reduced re-testing of products.
More accurate results (no human intervention, for
example in dilutions).
Use of people’s expertise in tasks other than sample
preparation.
Reductiori of waste generated by sample preparation
with a saving in waste disposition.
A partnership relation with Zymark that gave an
opportunity to solve any situation and help improve
the methods.
Automated acetyl analysis of cellulose acetates
Ralph Bandy
Eastman Chemical, Kingsport, TN, USA
The acetyl analysis of cellulose acetates has been auto-
mated utilizing a Zymark robot for sample preparation
and potentiometric titration to detect and quantify the
acetate ion formed by saponification of the ester samples.
The procedure for the acetyl analysis of cellulose acetates
involves solvation of the ester sample in a suitable solvent
followed by hydrolysis of the acetyl groups using a strong
base. Any residual base is titrated to an initial end-point,
followed by titration of the acetate ion at the second end-
point. The manual potentiometric procedure is both time
consuming and very technique dependent, making an
excellent candidate for automation. The system incorpo-
rates a Visual Basic Graphical User Interface (VB-GUI)
developed in-house to serve as an interface between the
analyst and the robot system. The VB-GUI also serves as
an interface between the analyst and the laboratory
LIMS system allowing automated data transfer.
Automated immersion testing
Alex W. Gutierrez
US Army Research Laboratory, Weapons and Materials Research
Directorate, Aberdeen Proving Ground, MD, USA
An intelligent robotic work cell has been developed to
perform immersion testing of polymer composite test
specimens. Immersion testing involves measuring weight
changes in the composite specimens as a function of the
time that they are immersed in water at a particular
temperature. The robot automatically handles test speci-
mens, operates equipment, and measures the amount of
water absorbed by each specimen. Traditionally, immer-
sion testing is a labour intensive procedure that involves a
repetitive sequence of operations such as transferring
liquids; blotting and weighing specimens; measuring
specimen thickness and recording data. Through auto-
mation, the robot can handle many test specimens and
immersion testing can be done 24 hours per day, and
seven days per week. This not only improves the accuracy
and reproducibility of results, but can facilitate the
production of an enormous amount of data. This quanti-
tative information is required to assess environmental
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durability and to guide the specification, design and
manufacture of composite materials.
Automated titration system for the assay of
absorbent gel materials in diapers
Kyoko IdA, Shunji Ishigam and Dean L. DuVal
Procter & Gamble Far East Inc., Kobe, apan
The present manual method to quantitatively determine
Absorbent Gel Materials (AGM) in diapers (nappies)
involves an extraction procedure followed by an acid-
base titration. However, this method is laborious and
time-consuming. It requires six hours for two people to
analyse 40 diapers. To overcome this situation, Procter &
Gamble Far East has introduced a fully automated
titration system by integrating a robot, automated ex-
traction baths and an autotitrator. The novel system
contains a Zymate XP robot, three sample racks (36
pads/rack), a Mettler titrator, three bubbling extraction
baths, pumps, balances and a waste container.
A paddle mixer was previously used to facilitate extrac-
tion of the AGM out of diapers. However, this method
requires skilled personnel and a fairly long sample-
preparation time. A new bubbling air method was
developed and the results give more than 98% recovery
after 6min bubbling. Three bubbling extraction baths
are used simultaneously, providing a greater number of
sample preparations per unit of time.
This robotic system was developed to automatically
prepare samples, reactAGM with excess HC1, and titrate
the excess HC1 with NaOH. The amount ofAGM in the
diaper is automatically calculated.
Use of a Zymark robotic system for acid-digestion
with microwave technology
Norbert E. W. Mueller and Bernhard Ciommer
Hoechst AG, Frankfurt, Germany
The digestion of mineral and organic samples is the most
important preparation step for element specific analysis
by means of AAS- and ICP-techniques. It forms the
essential basis for reliable results; errors in this stage of
analysis cannot be corrected later. So these marginal
requirements initiate the development of a universal
digestion robot to get qualitative high grade reproducible
digestions of organic substances for the atomspectro-
metric measurement.
The automation should certainly not be realized at the
expense of flexible handling of samples and digestion
conditions. Many pilot tests had to be made for combin-
ing test sample series and single individual samples. The
final result was a flexible automated system, which is able
to do quite varied samples series but also a single sample
in one digestion cycle. The system was designed in co-
operation with Zymark and Maassen/Berghof (specialists
in microwave techniques).
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Strategies for integration of combinatorial chem-
istry synthesis and screening
Richard Kris
Selectide/HMR, Tucson, AZ, USA
Combinatorial chemistry has grown to become an im-
portant part of the biotechnology and pharmaceutical
industries. Combi-chem raises some specific concerns for
high-throughput screening programmes. One is flexibil-
ity. As unique libraries are produced each week or each
month, for some only one project will be screened in
detail (with multiple concentrations tested for each
compound) while for others several selected projects will
be screened at single concentrations. Hence the author’s
application of high throughput combi-chem screening
has implemented a fairly large integrated system
equipped with the hardware necessary for running assays
for all current projects. Another concern is integration of
screening with synthesis. Selectide/HMR is complemen-
tary microplate-based Zymate systems for synthesis and
screening. Selectide/HMR’s experience in automation
and integration of combinatorial screening and synthesis
was the focus of this presentation and of the next
presentation by Stephen Felder.
Strategies for automated microplate synthesis of
combinatorial libraries
Stephen Felder
Selectide/HMR, Tucson, AZ, USA
The presentation reported on a system for synthesis of
Combi-Chem libraries in microplates. Libraries are
produced either as large collections of individual com-
pounds-useful for profiling and optimization of an
existing lead compound, or as a large collection of
mixtures--to help search for novel chemical leads. The
system uses a work-station approach. One station is for
down-stream processing of synthesized compounds-
washing, deprotection, either cleavage from resin or
extraction of product, and preparation of the compounds
for use. The other station is a multi-functional work-
station for synthesis. Each function is run as a batch
process for all of the microplates according to library
design. Use of this approach for production of Non-
Iterative Deconvolution Libraries was presented.
Implementation of an automated
purification verification system
preparatory
Michael Routburg, Roll Swenson, Jill Hochlowski,
Philip Serole, Bob Schmitt, Gene Maslana,
A1 Washington, Boris Minin, Sandra Mueller and
Ken Matuszak
Abbott Laboratories, Abbott Park, IL, USA
Abbott Laboratories is involved in creating single com-
pound libraries by parallel synthesis. It has been found
that the samples often lack the desired purity. There-
fore, a purification process is sometimes required. This
presentation focused on Abbott’s approach to the auto-
mation of the purification of parallel synthesized com-
pounds, and the integration of that process with the mass
spectrum verification of compounds, which have beenAbstracts of papers presented at the 1996 ISLAR
prescreened through an analytical HPLC and subdivided
by purity and by quantity. The development and im-
plementation process of the system were discussed, along
with the methodology, selection criteria, direction of the
automation, what worked and what did not, what was
suitable and what was not.
Efficient high throughput quantitative analysis in
Glaxo Wellcome’s Division of Bioanalysis and
Drug Metabolism
Julie Tomlinson
Glaxo Wellcome, Research Triangle Park, ArC, USA
During Glaxo-Wellcome’s post-merger integration ef-
forts, a project was undertaken to examine efficiency in
the international division of Bioanalysis and Drug Meta-
bolism. That project and its team were called High
Throughput Quantitative Analysis (HTQA). The divi-
sion of Bioanalysis and Drug Metabolism is made up of
departments that perform analytical support for discov-
ery, ADME and clinical, plus a strategic technology
group and a systems support group. A 14-member team
of scientists was formed with UK and US representatives
from each of those five departments. The HTQA team
collaborated to perform an evaluation, decide on solu-
tions and make short-term and long-term implementa-
tion recommendations to management. They evaluated
automated instruments and procedures, detection sys-
tems and work-flow across two US and three UK sites.
Their recommendations--which were unanimous--took
into account similarities and differences in HTQA needs
between the sites and applications.
Automated HPLC methods for the analysis of
Zaleplon and metabolites in human plasma and
urine
D. M. Rushworth, R. Unczowsky, P. Amorusi and
S. Tse
Wyeth-Ayerst Research, Pearl River, ArY, USA
Zaleplon is a non-benzodiazepine sedatime/hypnotic
agent currently in clinical development. The analysis
for Zaleplon and the des-ethyl metabolite in human
plasma and urine was conducted using a high perfor-
mance liquid chromatography (HPLC) method. The
assay was initially validated using a manual extraction
procedure which was tedious and labour intensive. Since
Zaleplon and the des-ethyl metabolite are stable in
human plasma and urine, this assay was an ideal
candidate for automation. The HPLC method for the
analysis of Zaleplon and the des-ethyl metabolite in
plasma and urine was validated with automatic sample
processing using a Zymate II Plus robot. In this method,
sample aliquots were loaded into refrigerated racks on
the robotic system. The Zymate robot was configured
with the following modules: Dilute and Dissolve; Cen-
trifuge; Test Tube Dispenser, TurboVap Evaporator and
Reodyne Injector. The analytes were separated with a
Beckman LC-8 column and monitored by fluorescence
(460nm). This method has been successfully validated
over a linear range of 0"5-100nm/ml in human plasma
and 2-2500ng/ml in human urine with coefficients of
variant < 10% and bias < +15%. The validation results
of the robotic extraction compared favourably to the
validation results of the manual method. The advantages
of using the Zymate robotic system in bioanalysis include
uniformity of sample processing and treatment, minimiz-
ing analyst contact with biological and chemical hazards
and improvement in laboratory productivity by freeing
up the analyst’s time from tedious and repetitive sample
preparation steps.
Enhancing productivity for bioanalytical assays:
utilization of automated SPE isolation and
MS for steroid analysis
Timothy Getek, Walter Mei and
Shankar Hariharan
Forest Labs, Inc., Farmingdale, ArT, USA
Advanced state-of-the-art analytical instrumentation,
such as LC/MS/MS, has allowed the analyst to run a
large number of samples (100 to 300) in one day by
utilizing shorter chromatographic times. In order to keep
up with the pace of the analysis speed, a rapid procedure
of extracting the analyte from biomatrices was needed;
this meant automating the process by which samples
were prepared. In this presentation, a case study of the
analysis of several steroids from biomatrices was dis-
cussed. The analytical protocols were rapidly developed
(typically, less than three days) at levels of 150 pg/ml in
plasma. The combination of an automated SPE system
and LC/MS/MS permitted the rapid analysis of a large
number of samples in a few days. Rapid throughput of
the data was complemented using a computer network
which allowed for speedy data processing via commer-
cially available database software.
The RapidTrace in the contact bioanalytical lab-
oratory: impact on data quality and sample
throughput
P. Zavitsanos and Joe Palantra
Biovail Corporation International, Toronto, Ontario, Canada
Acyclovir is an antiviral compound currently under
analysis at Biovail Corporation International. The assay
is analysed by HPLC-UV with a Level ofQuantitation of
5 nanograms per millilitre. Extensive data for the manual
extraction of this compound exists in the laboratory and
serves as a good baseline for comparison to the newly
implemented automated technique, solid phase extrac-
tion using the RapidTrace Workstation. The presenta-
tion compared the precision and accuracy data of
manual to automated techniques, as well as average
comparative time lines per batch. Impact on sample
throughput of the automated system was examined, in
addition to projection of future sample throughput
improvements.
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Automated ion exchange extraction for quantifica-
tion of a synthetic amino-acid drug candidate by
LC-MS-MS
Christopher Payne, Guy Carter, Gary Whiffin and
Richard Lachno
Lilly Research Centre, Surrey, UK
LY35470 monohydrate is a synthetic amino acid ana-
logue of glutamate that is being investigated for utility in
various CNS disorders through activation of mGluR2
and mGluR3 receptor subtypes. An LC-MS-MS assay
has been developed to quantify levels of Ly354740 in
plasma from human volunteers. Deproteinized plasma
extracts were purified by automated strong anion ex-
change chromatography using a Zymark RapidTrace
solid phase extraction workstation. The positive fluid
displacement design of this apparatus, where eluent
delivery is controlled by syringe pump, allows the low
flow rates necessary for efficient ion exchange. Batches of
up to 150 samples have been processed in approximately
4h. Further purification of samples is performed chro-
matographically by an on-line column switching system
prior to quantification of LY35470 using a Sciex AP
III+ with heated nebulizer interface. The assay is
extremely robust in operation, as well as being accurate
and precise. To date over 1000 clinical samples have been
analysed in the range of 2-100 ng/ml.
High throughput solid phase extraction for bio-
analytical applications
George Hutchinson
Anachem Ltd, Luton, UK
Christopher Fraudeau
Gilson Medical Electronics, France
and Marisue Paulus
Gilson Inc., Middleton, WI, USA
The power and reliability of solid phase extraction (SPE)
is now well proven and this sample preparation tech-
nique is widely used for a variety of compounds in an
extensive range of biological matrices. As modern analy-
tical techniques, such as LC/MS, enable shorter run
times the throughput of the sample preparation becomes
an important goal in method optimization. This pres-
entation described a novel approach to the automation of
conventional solid phase extraction cartridges using new
hardware. By taking a minimal list approach to method
design, optimization of chemistry, correction selection of
sorbent mass and identification of critical extraction
parameters, a throughput of more than 50 biological
samples per hour can be achieved.
Automation of extraction procedures for Zaleplon
and various metabolites in biological fluids using
the ASTED (Automated Sequential Trace Enrich-
ment of Dialysates Sample Processor) coupled to
HPLC
M. Milisci, K. Tantillo, P. Amorusi and S. Tse
Wyeth-Ayerst Research, Pearl River, NY, USA
The Gilson ASTED system employs a dialysis technique
to separate low molecular weight analytes from complex
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biological matrices such as plasma, urine, and blood. The
dialysis membrane used on the ASTED has a molecular
weight cut-off of 15000. High molecular weight com-
pounds, such as proteins, that normally interfere with the
HPLC separation and quantitation of analytes are ex-
cluded from the ’filtered’ recipient side of the membrane
containing the dialysates. Since this one-line deproteini-
zation process dilutes the dialysates, a trace enrichment
column (TEC) is used to concentrate the analytes of
interest just before injection. The TEC is typically a small
column containing a suitable packing material that has a
high affinity for the compounds of interest. The HPLC
mobile phase is then used to selectively elute the retained
analytes from the TEC onto an analytical HPLC col-
umn. The ASTED system has been used as an automated
on-line sample preparation procedure for biological
samples that normally require tedious extraction, con-
centration, and clean-up procedures before HPLC injec-
tion. This system has been validated and used for the
routine analysis of Zaleplon (a no-benzodiazepine seda-
tive/hypnotic agent) and several metabolites in human
plasma and urine. The linear concentration range for
Zaleplon and the desethyl metabolite in plasma and
urine was 0-5 to 100ng/ml. The concentration range
for the M1 and M2 metabolites in plasma was 25 to
5000ng/ml. Inter-day precision (SD) and accuracy
(%bias) were < 10% and < 16%, respectively, for all
analytes.
Extraction of broad range compounds using solid
phase technology
Margaret Raisglid and Michael F. Burke
University of Arizona, Tucson, AZ, USA
Solid phase extraction has proven to be an effective
technique for isolating and concentrating a broad range
of compounds from a variety of matrices, one of the
challenges has been selecting sorbents and solvents that
are suitable to extract a broad range of compounds from
a single sample. Although it is possible to select a phase
and conditions that will optimize overall recoveries for a
given type of sample, the recoveries of some of the
individual compounds may be compromised. For
example, a sample may contain analytes that range from
small polar molecules to large hydrophobic molecules. If
a short chain modified silica, such as C2, is chosen as the
bonded phase, the large compounds can be retained, and
subsequently eluted, but the small, polar compounds will
pass through the extraction bed unretained. Alterna-
tively, a long chain modified silica, such as C18, may
be used for the extraction. Although the full range of
compounds may be retained, it is often difficult to elute
the large, hydrophobic compounds. An alternative to
using an extraction cartridge containing a single bonded
phase is to layer different sorbents in a single cartridge.
The remaining challenge is to characterize the sorbent
and solvents using stacked columns and then optimize the
layered column for use with automation. Examples using
segeral unique combinations, which are compatible with
the AutoTrace unit, were presented. Layered columns
have proved to be an effective approach for optimizing
recoveries for broad range analytes.Abstracts of papers presented at the 1996 ISLAR
In vitro drug interaction studies in drug discov-
ery-higher throughput methods
Diane Johnson, John Janiszewski and
Donald Tweedle
Pzer Inc., Groton, CT, USA
Drug metabolism studies are providing key information
in drug discovery to assist in the selection of new drug
candidates. The challenges of analysing large numbers of
compounds in a timely manner have necessitated new
approaches. Technologies used for high throughput
pharmacology screens are being applied to conduct
metabolism studies. Initial metabolism screens have been
estabished to conduct in vitro drug interaction studies.
These studies can be used to predict the potential for in
vivo drug-drug interactions and can also indicate which
individual enzymes may be involved in the metabolism of
discovery compounds. These inhibition studies generate
IC50 values (drug concentration to inhibit enzyme
activity in the absence of inhibitor by 50%). Routine
assays have been established in 96 well plates to measure
inhibition of the major isoforms of cytochrome P450, the
family of enzymes primarily responsible for the metabo-
lism of drugs. Conducting these assays has presented
problems related to enzyme lability, sensitivity to organic
solvent concentration, and timely analysis of large num-
bers of samples. Examples of the approaches being taken
and the data generated were provided.
Benchmate assisted-chlorophenoxy acid herbi-
cides urinalysis method for biological monitoring
of exposed field applicators
K. K. Brown, A. W. Teass, L. E. Stettler and
c. J. Hines
U.S. National Institute for Occupation Safety and Health,
Cincinnati, OH, USA
A biological monitoring method was developed for the
determination of the chlorophenoxy acid herbicides, 2,
4-dichloro-t-methoxybenzoic acid [dicamba], 3-(2,4-di-
chlorophenoxy)propanoic acid [dichlorprop], 2,4-di-
chlorophenoxyacetic acid [24D], 3-(2,4,5-trichlorophen-
oxy)propanoic acid [245TP], (2,4,5-trichlorophenoxy)
acetic acid [245T], and 4-(2,4-dichlorophenoxy)butanoic
acid [24DB] in urine. Chlorophenoxy acid herbicides are
difficult to analyse by broad multi-residue analytical
methods because of their high polarity and ionic proper-
ties. These compounds required derivatization for GC
analysis, and the derivatizing reagent varies among
published methods. This present method derivatized
using pentafluorobenzyl bromide [PEB]. Unique to the
method was the use of solid phase extraction [SPE] that
made it amenable to automation. BenchmateTM auto-
mation allowed for overnight unattended sample pre-
paration assistance with computer file documentation of
each step. An internal standard [IS], the PFB ester, of
2,4-dichlorophenyl acetic acid [24DP], was used for
quantification and quality control, and an internal
instrument performance standard [IIPS], dinoseb methyl
ether was used to monitor instrument performance.
Sample preparation was assisted using a BenchmateTM
robotic workstation. Samples were acidifed with phos-
phoric acid and fortified with internal standard, 24DP,
each at a concentration of 100ng/ml. The calibration
urines were blank urine samples fortified with herbicide
standards. The herbicides and internal standard were
extracted from the urine samples using C18 SPE car-
tridges, and eluted with acetone into tubes containing
pentafluorobenzyl bromide and cesium carbonate. After
10 minutes of reaction time, the solutions were trans-
ferred to tubes containing hordenine that quenched the
reaction, by consuming the excess pentafluorobenzyl
bromide. Dilute sulphuric acid was added to the
quenched reaction mixture, and the 35% aqueous solu-
tion was passed through a second C18 SPE cartridge, the
pentafluorobenzyle esters were retained on the columns,
and were eluted off with toluene. 2-(1-Methylpropyl)-
4,6-dinitrophenol (dinoseb) methyl ether was added to
each final extract as an internal instrument performance
check. The extracts were analysed by capillary GC with
electron capture detection.
Urine samples were analysed in batches of 30 7"0ml
samples consisting of 16 field urine samples, eight cali-
bration urines, three quality control urines, a blank
urine, and a water blank. Quality control was main-
tained for each sample by monitoring the peak height
response (mV/ng) of the internal standard and the
internal instrument performance standard. Shewhart’s
control charts of the dinoseb response and chromato-
graphic efficiency (N, theoretical plates) monitored the
performance of the instrument for each sample, and
detected instrument failure. Control charts of the internal
standard response monitored the performance of sample
preparation for each sample. If the internal standard
response was out of control, the robotic data audit trail
allowed for diagnosis at the sample preparation step.
Traditional batch quality control was also obtained by
monitoring the response of quality control samples,
replicates, and water blanks. Thus, the quality of each
data was assured. Data processing and record keeping
was facilitated by the direct linkage of Benchmate and
chromatographic data files to a preprogrammed spread-
sheet, which were stored on optimal disks.
The present method produced a linear detector response
from to 1000ng/ml. Percentage relative standard
deviation for 24D averaged 7% above the LOD. Batch
limits of detection for dicamba, dichlorprop, 24D,
245TP, 245T, and 24DB averaged 34, 6, 9, 24, 19, and
18 ng/ml, respectively. Thus far, field samples ranged in
2,4-D concentration from the LOD to 326 ng/ml.
Automation in the oligonucleotide synthesis lab---
the workstation approach
Burr Goodman, Joel Boymel, Cheryl Johnson,
Brian Governski, Julie Ross-Kramer,
David Van Ausdall, Ted Jones and
William S. Marshall
Amgen Inc., Boulder, CO, USA
The DNA Technology Group at Amgen-Boulder is
responsible for the synthesis of all oligonucleotides for
Amgen Inc. The process of automated DNA synthesis
was approached using a ’workstation’ rather than a
’system’ approach. Using this approach, and integrating
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the use of commercially available DNA synthesizers,
flexible workstations were developed that perform the
following functions: vial sorting and decapping, solid
phase extraction, and liquid transfer. The entire process
is tracked by a database system developed in-house. The
process of oligonucleotide synthesis, as well as the func-
tion and performance of these workstations, was exam-
ined.
The development of an automated high through-
put screening system
D. Harding
Thurnall plc, Manchester, UK
The automation of high throughput screening is rapidly
gaining acceptance in the drug discovery world. This
paper described how one such facility was developed, the
flexibility of the final system, and the design process
required to produce an ’industrial’ level of reliability
and robustness. The facility was developed for Glaxo
Wellcome’s Medicines Research Centre in the UK. It
consists of two robot systems, one handling isotopic
assays, the other non-isotopic work. The facility is
designed to handle both 96 and 384 microtitre plates.
Standard instruments are used, with the exception of
incubators and the bulk reagent dispenser where instru-
ments were developed especially for the application.
The two systems are controlled by Thurnall’s SPRINT
software system--a Windows
TM based scheduling system
providing significant user flexibility, while remaining
user friendly. The facility was developed to meet specific
customer requirements within a short timescale. The
project lifecycle was described to show how the initial
requirements were converted into a working system.
The use of reactive fragment structure transfor-
mations for automated structure generation in
automated combinatorial chemistry with applica-
tions to diversity analysis
John Cargill
Ontogen Corporation, Carlsbad, CA, USA
Computer programs for the automated generation of
molecular structures are required to handle the volume
of data produced by recent advances in combinatorial
chemistry. Typically a list of reagents and a reaction
template are provided as input to these programs and a
set of structures is generated as output. One demon-
strated approach to this problem is based upon a
parent-substituent model. In the Ontogen approach,
the structure of each reagent is specified to the graph
structure of the reactive fragment that is incorporated
into the desired structure post-synthesis. By specifying the
connection points among the fragments, the final struc-
ture can be generated without the limitation of an
invariant parent fragment. The reactive fragment ap-
proach is universally applicable for the many reactions in
which a parent-substituent approach fails. In addition,
the application demonstrates a method of diversity analy-
sis utilizing reactive fragments which has several desir-
able features.
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A robotic system for agar diffusion testing
Morten Heide
Novo Nordisk A/S, Novo Alle, DK 2880 Bagsvaerd, Denmark
Jan Madsen and Nils B. Jensen
Novo Nordisk Engineering A/S, Krogshoejvej 55 DK 2880
Bagsvaerd, Denmark
A robotic system for screening for anti-microbial activ-
ities against agar imbedded target micro-organisms has
been developed and implemented at Novo Nordisk A/S.
The system can carry out high throughput screening of
extract collections for anti-microbial activity against up
to 40 different target organisms per run. An Adept One
robot is used for moving the sample racks and the target
plates between the two storage hotels and the working
platforms. On each target plate a 9 x 9 array of holes is
punched by the robot using a custom designed tool. To
avoid carry over between plates with different target
organisms, the tool is cleaned in a solvent between the
plates. The solvent and the surplus agar from the plates
are removed using vacuum and collected in a freeze trap.
The samples are distributed to the target plates by the
robot using a high performance pipetting system with
nine individual syringes. The pipetting tool is equipped
with needles for penetrating the septa on the sample vials.
To avoid carry over, the pipetting tool is cleaned in a
solvent between samples.
After incubation the clearing zones are scored with
regard to size, shape and turbidity using a vision system.
The images and scores are transferred to a database. To
protect the targets against foreign organisms, the system
is enclosed in a hood with a sterile laminar airflow.
Eight steps for non-programmers to write a
Windows-based instrument controller
Michael J. Shea
Recombinant BioCatalysis Inc., Sharon Hill, PA, USA
To unite an instrument controller with a Windows
interface it is not necessary to be an expert programmer.
With the aid of Visual Basic, and other design tools and
techniques, instrument control programs can be written
with little programming background. An eight-step
approach for writing control programs was described. A
terminal program that can help in understanding the
instrument was discussed. This also includes codes that
can be reused for the implementation of new instrument
control programs. This presentation described the com-
plete creation of an instrument control program for an
SLT Spectra Shell Reader instrument.
Automated high throughput mass spectral analy-
sis of oligonucleotides
David Van Ausdall and William S. Marshall
Amgen Inc., Boulder, CO, USA
The DNA Technology Group at Amgen, Inc. currently
produces an average of 10 synthetic oligomers per day,
all requiring quality assurance analysis. The addition of
Delayed Extraction (DE) technology to Matrix Assisted
Laser Desorption Ionization-Time of Flight (MALDI-Abstracts of papers presented at the 1996 ISLAR
TOF) mass spectrometry enables the rapid mass analysis
of multiple oligonucleotide samples. A Bohdan liquid
spotting Automated Work Station (AWS) has been used
for precise and repeatable sample placement, and a
PerSeptive Biosystems Voyager DE MALDI Mass Spec-
trometer (MS) provides high throughput analysis of
synthetic oligonucleotides. Prior to the development of
these systems, the only methods of analysis with sufficient
throughput were trityl cation analysis and polyacryla-
mide gel electrophoresis (PAGE). Unfortunately, PAGE
can only give a qualitative analysis of the product and is
unable to unambiguously verify the identity of the
oligomers. The DE MALDI MS is able to determine
the mass of each sample within approximately 0"1% of
the expected mass. This accuracy means that the identity
and purity of all oligonucleotides produced can be
determined with an unprecedented degree of confidence.
Using this automation suite, sample preparation, spot-
ting and analysis of 100 samples can be completed in less
than 90 minutes.
A comparison of the Waters Tablet Processing
System and Zymark Table Processing Work-
station II
John R. Stanley
SmithKline Beecham Pharmaceuticals, Hertfordshire, UK
The Waters Tablet Processing System (TPS) is the only
all-in tablet analysis package on the market which is not
a customized system and, as such, is the main competitor
to the Zymark Tablet Processing Workstation II (TPW
II). In both cases, the end result is the processing of
tablets and capsules but these two instruments are very
different beasts. The TPS consists of a Source for
Automation tablet processor married to a Waters HPLC
set-up. The tablet processing control software and data
analysis software (Waters Millenium) are inter-linked,
which, in theory, allows the operator to obtain quanti-
tative data in one seamless process. The TPW II, on the
other hand, exists as an extraction tool and can be linked
to most HPLC (or UV detectors) and data analysis
packages which will have to be purchased separately
from the TPW II.
To compare the extraction, ease of use and robustness of
these instruments, a tablet and capsule formulation were
analysed. The table extraction process was optimized
using a fractional factorial approach (using Design Ease
software), which highlighted not only the optimal but the
critical extraction parameters. Ease of use and robustness
were determined by user friendliness and reliability. The
advantages and disadvantages of the TPS and TPW II
were discussed.
Remote control of Zymate peripheral devices with
a PC
Steve iichalczyk, Jeff Russell, Jennifr Semanchik
and Kyeong Yeo
Bristol-Myers Squibb, Princeton, NJ, USA
Zymark Corporation currently offers several peripheral
devices to provide controllable syringe pumps, valves,
relays and other electro-mechanical functions to the
robotic workcells. Although they are intended for usage
with a Zymate controller, these devices are intelligent
and can be controlled by an external computer provided
that their non-standard interface is translated to standard
RS-232 specifications. In this case, a system using non-
invasive hardware and providing a graphical user inter-
face was desired to enable the use of Zymark peripherals
outside of the traditional Zymark robotic workcell. The
first phase of this project entailed the design and im-
plementation of an interface to the Zymate Master
Laboratory Station (MLS). The interface comprises a
hardware serial communications bridge to translate RS-
232 signals to Zymate electrical specifications and a PC-
based device software driver which adheres to the per-
ipheral command protocol.
Automated inert atomosphere synthesis using the
Tecan CombiTec System
Stefan Loren, Robert J. Schmitt, Lisa M. Frey and
Thomas J. Sowin
Abbott Laboratories, Abbott Park, IL, USA
A series of 48 oxygen sensitive solid phase organic
reactions were carried out using the Tecan CombiTec
combinatorial chemistry workstation. Despite the need
for different incubation temperatures, 24 Suzuki and 24
Heck couplings were run in parallel in a single reaction
block to produce a library consisting of biaryls and
stilbenes. Prior to the introduction of the palladium
catalyst, the inert atmosphere of each indvidual reaction
vessel was measured by GC-MS. All experimental results
were reported.
Design, development and implementation of auto-
mated screening methods at Hoechst Marion
Roussel Research Institute
Brent T. Butler
Glaxo Wellcome Research, Research Triangle Park, NC, USA
Jan R. Davis, Steve Busch and Robert Singleton,
Hoechst Marion Roussel, Cincinnati, OH, USA
In the past several years there has been increased
external and internal pressures on the part of the
pharmaceutical industry to expedite the discovery and
thus the time to market of new chemical entities. This is
being accomplished with the use of robotics technology to
screen thousands of compounds for searching for that
next blockbuster drug. In 1994, Hoechst Marion Roussel
Research Institute, HMR (formerly Marion Merrell
Dow), invested in an automation laboratory and robotics
system for directed and profile screening. The automa-
tion laboratory that was designed employs two Beckman
Biomek 1000 robots with side loaders and a Zymark cell-
based robotic system that uses a Packard Multiprobe
104DT for liquid handling. These systems handle a
variety of assays including cell-based reporter gene
assays, ELISAs and enzyme assays. The Biomeks are also
used for creating daughter plates from compound stocks.
The facility has a separate cell culture lab which main-
tains and supplies the cells for cell-based assays. The cell
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culture room has a Zymark robot designed for plating
cells into 96-well plates.
The automated laboratory is currently capable of screen-
ing approximately 10000 compounds/week for directed
screens and 500 compounds/week for profile screening.
The data generated from these assays are downloaded to
an Oracle data base and analysed using ActivityBase.
The results are readily accessible to scientists throughout
HMR
Evaluating the feasibility of automated analytical
methods for the determination of drugs in medi-
cated animal feeds
Mark M. Walstead, Brian Mazur, Yacoob Haroon
Hoffmann-La Roche Inc., Fair Lawn, NJ, USA
and Ed Yapchanyk
Zymark Corporation, Hopkinton, MA, USA
An automated method based on the Zymark Tablet
Processing Workstation (TPW II) has been developed
for extracting Frenolicin-B from poultry feed. The pro-
cedure weighs ground feed samples, adds solvents, and
extracts Frenolicin-B by homogenization. After auto-
mated filtration, the samples are injected and analysed
using liquid chromatography.
Automation of this application reduced analyst time from
3-5h to 30min for 25 samples. The accuracy and
precision data for this analysis were similar to those found
when samples were extracted employing more traditional
methodologies.
Implementation of this technique for routine extraction
of Frenolicin B from Type C medicated feeds was
described.
Validation of automated methods for ReVia tab-
lets
j. A. Short and K. R. Lung
The DuPont Merck Pharmaceutical Company, Wilmington, DE,
USA
Revia(R) (Naltrexone Hydrochloride) is a DuPont Merck
drug that has been approved in the US and Canada for
the treatment of alcoholism. This drug is formulated in
the form of a coated capsule-shaped tablet. Due to the
high volume of release and stability testing required to
support the NDA activities, automated sample prepara-
tion methods were develo]ed for assay and content
uniformity testing of ReVia.
Initially, the automated sample preparation methods
were developed on the XP-arm based Zymate Tablet
Processing Workstation (Zymate-TPW). Eventually, the
assay method was adapted to the BenchMate Tablet
Processing Workstation (BenchMate TPW).
These automated methods have been validated and were
shown to be equivalent to the manual method. The
validation of the method on the Zymate TPW and
cross-validation of this method with the manual method
7O
were discussed. The cross-validation between the Zy-
mate-TPW and BenchMate TPW was also presented.
A break-even analysis model for the evaluation of
capital spending in laboratory automation
K. R. Lung, Cheryl Umbles and John DeMay
The DuPont Merck Pharmaceutical Company, Wilmington, DE,
USA
A finance model often used for the justification of capital
spending in laboratory robotics and automation is the
Payback Model. Although this model is simple and
intuitive, it is too one-dimensional and fails to capture
the dynamics among initial capital costs, efficiency
improvements and sample load in an automation project.
In addition, the Payback Model implicitly assumes the
replacement of laboratory personnel with robotic equip-
ment. However, the authors’ experience demonstrates
that the replacement of personnel with equipment does
not necessarily take place.
Automation certainly improves the efficiency of analyti-
cal laboratories through the use of robotic sample prep-
aration equipment and laboratory data processing tools.
Unfortunately, many of these robotic and automation
tools are costly and the high initial capital investments
often have to be evaluated and justified from a financial
perspective.
The Break-Even Model presents an automation project
as an X-Y graph, in which the cost of the project is
plotted on the Y-axis and the volume ofsamples is plotted
on the X-axis. Improvement in efficiency due to auto-
mation is represented by a lower slope in the cost-volume
curve. At the same time, the cost-volume curve for
automation is handicapped by a high initial intercept
associated with up front capital investment. The break-
even point is where the cost-volume curve for a non-
automated project (with a higher slope and lower inter-
cept) crosses the cost-volume curve for the automated
project.
The Break-Even Model summarizes the financial as-
sumptions of a typical, automation project and can assist
R&D Management in making investment decisions that
are both technically and financially sound. Representa-
tive examples of improvements in efficiency, comparing
projects that used automated sample preparation versus
projects that used manual sample preparation, were
presented.
Using the Biomek 2000 to automate an EIA for the
quantitation of polysaccharides
R. Charbonneau, W. Long, J. Hennessey and
L. Rubinstein
Merck & Company, West Point, PA, USA
A Beckman Biomek 2000 liquid handling system, utiliz-
ing a Zymark robotic arm, was used to replace a manual
EIA (enzyme immune assay) procedure for the quantita-
tion of Pneumoccocal polysaccharides. The procedure is
complex, involving the simultaneous microplate analyses
of eight different polysaccharide antigens and includes:
serial dilution of samples, plate washing, sequentialAbstracts of papers presented at the 1996 ISLAR
addition of reagents and optical quantitation of a colori-
metric reaction. The manual procedure is tedious, time-
consuming, and prone to operator error. The robotic
procedure is fully automated, requiring operator inter-
action only for initial setup and final data download into
an Excell spreadsheet for analysis. The Bioworks software
allows a variable number of plates to be manipulated
without program alteration. The robotic arm provides
the Biomek 2000 with labware, including pipette tips and
reagents. Additional reagents, including a detection
reagent stored on ice, are provided via a peristaltic pump
connected to a multiport valve.
Robotic system for the analysis of semi-solids in a
quality control laboratory
M. Mercenari
Schering S.p.A., Milan, Italy
Robotics can decrease analytical costs and thus increases
the profit margins of drug manufacturers. Therefore
Schering S.p.A. and FKV, Sorisole (BG), representative
of Zymark Corporation, USA, co-operated to try to
obtain an automated system for the analysis of semi-
solids.
The development of the robotic system involved four
steps:
Study: the parameters of the methods used for the analysis
of semi-solids were examined to check the necessity and
the frequency of the changes to be made for analysing
different products. Then the feasibility of dosing the
components of most of the products without human
intervention was checked.
Project: foundations were laid for the realization of the
robotic system by checking the compliance of the tech-
nical answers to the requirements in the study phase.
Realization: various working stations of the robotic system
were built and assembled to verify the connection
between the different devices. This phase was realized
by FKV and ended only when every working station
worked perfectly, either separately or connected with the
other.
Validation: this began after the definitive installation in
Schering’s laboratory and involved checking the meth-
od’s ruggedness, product by product, which was done by
means of statistical calculations. This was the most
delicate phase, where the practical, ’not robotic’ prob-
lems occur and have to be solved, because they cause
difficulties in the use of the automated system.
Comparison of manual versus automated content
uniformity analysis of pharmaceutical solid do-
sage forms using the Zymark TPW II
John Kerr
Glaxo Wellcome, Inc., Greenville, NC, USA
One of the most common tests requested during devel-
opment of new solid dosage forms of a particular drug is
content uniformity. Depending on the matrix, manual
preparation time per sample can range from minutes to
hours. These lengthy procedures result in inefficient use
of the analyst’s time and training.
This presentation demonstrated the potential time and
cost savings benefits in converting lengthy manual meth-
ods to automated methods for two solid dosage forms.
One product required over three hours to manually
prepare one sample for content uniformity analysis. With
some modification, the method was reduced to 10 min of
preparation time, including time for injection onto
HPLC, using the TPW II. A second product required
over one hour of sample preparation. Again, with some
modification, the preparation time was reduced to min-
utes. Comparison of the cost savings using the automated
versus manual methods was discussed.
BenchMate automates DNPH preparation of PPM
aldehydes in aqueous samples
Stephen L. Wellons et aL
Union Carbide Corporation, South Charleston, WVA, USA
A Zymark Benchmate has been used to automate the
sample dilution and 2,4-dinitrophenylhydrazine
(DNPH) derivations previously done manually. This
labour intensive procedure took an experienced techni-
cian about 15 min per sample. The Benchmate procedure
only takes about 3 min (per sample) of technician in-
volvement and requires less expertise on the operator’s
part. The procedure is applicable to samples that are
aqueous or miscible in water. The automated procedure
was found to be equivalent to the manual one and works
for concentrations of aliphatic aldehydes (glycolalde-
hyde, formaldehyde and acetaldehyde have been tested
so far) from several hundred down to ppm. The
reactants are cleaned up on C-18 solid phase extractions
(SPE) cartridges. The resulting solutions are analysed by
liquid chromatography (LC). Fractional factorial de-
signed experiments were used to determine the principal
effects of the procedural steps. The components of
variance between the Benchmate and LC portions were
estimated using nested designed experiments.
PGB determination in transformer oils sample
preparation with BenchMateTM SPE-Workstation
and TurboVap
(R) SPE-Workstation
Andrea Joeris-Viethen and Regine Weber
GEW KO’ln, Germany
According to the PCB-Verbotsverordnung of 1989,
which is now part of the Chemikaliengesetz, it is no
longer permitted to operate transformers with cool and
isolation oils that have more than 50mg/kg total PCB
content according to LAGA. The determination of the
PCB content follows DIN 51 527. There are six PCBs
specified, which are determined vicarious for the total
PCB content given by LAGA (sum of six PCBs multiplied
by five). The samples of transformer oils are cleaned up
by liquid chromatographic preparation and the sample
concentration can be automated conveniently and reli-
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ably by the BenchMate SPE Workstation and TurboVap
LV Evaporator.
Development of a fully automated flow injection
system
Michael J. Tutor and Seth Gilmore
VMI Research Laboratories, Lexington, VA, USA
Flow Injection Analysis(FIA) is a very popular tech-
nique. It is inexpensive compared with batch automation
methods and it requires relatively simple equipment; it is
amenable to a variety of analyses, conserves reagents,
reduces contact with possibly hazardous chemicals, and is
often many times faster than batch methods of analysis.
The VMI Intelligent Automation Group is developing a
fully automated FIA system. With the use of the Lab-
View 4.0 graphical interface programming software, a
point and click interface has been created to allow
minimal training to operate the system. The system
consists of a variable size syringe pump, an automatic
sample injector, a digital I/O board that controls a set of
solenoid valves, and a spectrophotometer. The FIA
system has been used to automate the analysis of several
metal ions, including Co(II), Fe(II), Pb(II), and Hg(II).
Modification of standard methods of water analy-
sis to simplify the adaptation to flow injection
analysis
Michael J. Tutor, Seth Gilmore and Aaron M.
Hamilton
VMI Research Laboratories, Lexington, VA, USA
Flow Injection Analysis(FIA) is a popular means of
laboratory automation. It is fast, economical, conserves
reagents, reduces contact with dangerous materials, and
is also flexible in the types of analyses that can be
performed. A system consists of a pump for the reagents,
an injection valve to inject the analyte and a reaction coil
that leads to a spectrophotometer. FIA can also accom-
modate in line extraction cells for hazardous or complex
separations.
Standard methods that require heating or waiting peri-
ods to allow a complexing reaction, or extraction tech-
niques involving organic reagents make the use of FIA
impossible or extremely difficult. It is often much easier
to adapt methods to FIA than try to accommodate a new
or complex technique to the method. Methods that
require extraction, heating or waiting periods to allow
the complex to form can possibly be catalysed or
solubilized by the use of surface active agents.
The VMI Intelligent Automation Group is developing a
fully automated FIA system. Several batch methods have
been modified with the use of surfactants to accommo-
date the use of FIA. The standard dithizone method for
lead, mercury, cadmium, zinc, and copper requires a
liquid-liquid extraction with a nonpolar solvent; surfac-
tants have been used to eliminate this step. Surfactants
have also been used to eliminate heating and waiting
periods in the standard methods of cobalt and nickel.
Such modifications have made these methods easily
adapted to FIA.
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The modification of standard methods of analysis
of water for automation on a dual robotic system
Michael J. Tutor, A. P. Gehring and
Aaron M. Hamilton
VMI Research Laboratories, Lexington, VA, USA
One of the primary reasons that laboratories are auto-
mated is to increase the sample throughput by increasing
the speed and by reducing the human error that can
result in inconsistent data or the need to rerun samples.
Automation also has the potential of around-the-clock
operation. Many standard methods are not excessively
difficult to automate, but extensive procedures can
actually take longer on a robotics system than if done
mutually. It is often beneficial to consider adapting
certain methods to the robotic system as opposed to
adapting the robot to run these methods.
The VMI Intelligent Automation Group is using an in-
house colorimetric analysis program (SPECTRO) to
optimize and modify standard analytical methods for
use on a dual robotics system. The Spectro program is
designed to be broad and universal so that several new
types of analytes could simply be added to the system
without reprogramming the basic procedure. Several ions
(including lead, zinc, mercury, copper, cadmium, cya-
nide, aluminium, chromium, and cobalt) have been
optimized for automation. Certain methods, such as
aluminium and cobalt, underwent extensive modification
to ease the adaptation of these methods to automation
using the in-house program.
The Eriochrome Cyanine R method for determination of
aluminium is published as a procedure that involved
adding four separate reagents to the test solution to
produce the desired colour for detection. This procedure
was not compatible with the in-house colorimetric analy-
sis program. It was modified so that the reagents
responsible for the development ofcolour were combined,
and the combined ’colouring solution’ was then added to
the test solution, and then analysed after the required
time. This modified procedure is now compatible with
the in-house program.
The complexing agent 4-(2-pyridilazo)resorcinol(PAR)
is used in many standard colorimetric methods of analy-
sis. Cobalt analysis with PAR requires heating and
waiting periods, along with addition of masking agents
after the complexing reaction has occurred. This made
the automation difficult and time consuming. The meth-
od was modified using the surface active agent Triton X
100 to catalyze the reaction and eliminate the need for
heating and waiting periods (Tutor M. J., VMI Under-
graduate Research Review, vol. II, 3, 1996). These modifica-
tions made the method much easier to adapt to the in-
house system.
The design, construction and testing of a dual
robotic system
Michael (3. Zirkle
VMI Research Laboratories, Lexington, VA, USA
Two primary reasons for automating analytical methods
in a chemistry laboratory are to save time and to decrease
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being updated to include new scheduling algorithms and
other programs that allow the user to do more with less.
There comes a point where complex software solutions no
longer make significant improvements in performance,
and a new path needs to be followed. Rethinking the
hardware configuration is the next logical step.
The VMI Research Laboratories Intelligent Automation
Group, a multidisciplinary team composed of chemists
and programmers, has combined the Zymate II and
Zymate XP robotic systems, with in-house and commer-
cial software systems, to create a dual robotic system for
versatile colorimetric analysis under a Windows NTTM
environment.
A description of the automated system was presented
here, along with the requirements posed to the system
and the software and hardware utilized.
A novel microwave autoclave for automation of a
pharmaceutical research application
W. Lautenschlager, W. G. Engelhart and
M. Metzger
Milestone MLS, Riviera Beach, FL, USA
Hundreds of laboratories currently utilize microwave
systems to accelerate the preparation of samples for
research purposes, quality control and process control
analyses. Conventional microwave systems with multi-
code cavities and doors are designed for manual opera-
tion.
A new microwave autoclave eliminates the impediments
to automating microwave chemistry procedures. The
ultra CLAVE system combines microwave heating and
high pressure vessel technology allowing chemical reac-
tions to be conducted at pressures and temperatures up to
200 bar (2 900 psig) and 350C. The system is specifically
designed for semi-automated batch processing of multiple
samples. Full automation is achieved for interfacing a
laboratory robot arm to load/unload sample racks.
Fundamental design and operating principles of the
system were presented along with examples of pharma-
ceutical research applications performed in the system,
synthesis reactions, solvent extractions, peptide/protein
hydrolyses, acid digestion of implant materials, etc.
Radiopharmaceutical automated dosage system
Rodney Stockton
SLR Systems, Richland, WA, USA
James w. Pancy and Mark Nybo
Medi-Physics, Inc., @ring Lake, MI, USA
Radiopharmaceuticals are used in nuclear medicine for
various diagnostic and therapeutic procedures. Nor-
mally, the radiopharmaceutical is drawn into a dispos-
able syringe by a pharmacist. Although single dosages do
not present a health hazard to the patient, the prepara-
tion of 300 + dosages per day by the pharmacist presents
a considerable exposure hazard. This presentation de-
scribed an automated system for drawing radiopharma-
ceutical dosages into disposable syringes and placing
them into lead shields.
This system has been in operation for several months at
the Chicago facility of Medi-Physics, Inc. It is capable of
drawing 60 + doses per hour. Future modifications will
increase the throughput to 120+ doses per hour. The
system is based upon the Mitsubishi RV-M2 articulated
arm robot and custom hardware and software designed
(in conjunction with Medi-Physics personnel) by SLR
Systems. Manufacture of the system was performed at
SLR Systems’ facilities in Richland, WA.
The system is controlled via a 486 computer, pro-
grammed in Microsoft Visual Basic. Two microcontrol-
lers (BS2 from Parallax, Inc.) are incorporated to
provide intelligent digital I/O for sensors, pneumatic
slides, conveyors, and turntables.
Custom engineered automation for scientific re-
search
Ed Ball and Dave McCampbell
Midwest Research Institute, St. Louis, MO, USA
MidWest Research Institute (MRI) has been providing
contact scientific research for 50 years, in fields such as
energy, environmental, health, and transportation. Auto-
mation solutions have been provided for the laboratory
research scientist for almost 10 years. The automation
group is a multidisciplinary group with backgrounds in
mechanical engineering, engineering design, artificial
intelligence, computer programming, machine vision,
analytical chemistry, and biology.
Automation specialists at MRI have developed robotic
systems to increase the throughput and precision of such
tasks as natural pesticide screening, oncogene inhibitor
screening, biological matrix extraction, and mineral
content determination of food products. Some of the
custom systems and modules developed by the automa-
tion group at MRI were described.
Dimensional analysis of rigid polyurethanes with
Windows ’95
Steven E. Robbins and Michael E. Rusak
Air Products & Chemicals Inc., Allentown, PA, USA
Rapid polyurethanes are used primarily as insulation and
subjected to a variety of environmental conditions,
typically from 20 in commercial refrigerators to 160C
in ovens. The dimensional stability, or resistance to
deformation, is a key material property, indicative of
the material’s long term behaviour in the specific applica-
tion.
A Windows ’95 platform has been used to automate
sample manipulation, instrument control and data
acquisition. The system includes several controllable
sample carousel racks, dimensional measurement gauges,
positional control devices, optical sensors, and a mass
balance. This presentation described the operational
simplicity of a complex customized system as well as
some of the key building blocks used.
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Challenges and opportunities in high throughput
screening: implications for new technologies
John Major
ZENECA Pharmaceuticals, Macclesfield, UK
In response to mounting competitive pressures, the
current trend in the pharmaceutical industry is to shorten
the time scale for all aspects of drug discovery. While
advances in computation, structural chemistry and mol-
ecular modelling are facilitating rational design activities,
empirical screening continues to play a crucial role in
lead identification. Because the ability to test large
numbers of compounds quickly and efficiently can pro-
vide a competitive advantage, high throughput screening
(HTS) has become a key goal. To achieve the necessary
productivity, effective integration of compound supply,
assay operation and data management is essential. HTS
is a high technology enterprise that must take full
advantage of the latest advances in bioscience, biotech-
nology, engineering and electronics. There is a constant
dilemma, however, in relation to when well established,
mature technologies should be replaced by new methods
that promise to deliver spectacular advantages. The final
decision must be based on weighing up the promised
benefit against the cost and risk. While huge challenges
face the pharmaceutical industry, there are also oppor-
tunities for those companies that can identify and imple-
ment new technology effectively. The requirements for
efficient HTS and the implications in relation to assay
technology and automation were discussed.
Transforming robotics into an infrastructure for
the future
John Babiak
Wyeth-Ayerst Research, Princeton, NJ, USA
Advances in high throughput screening frequently occur
by interfacing new automated peripheral devices or
workstations which perform critical functions onto an
existing robotic core system. In the past, these interfaced
devices have included liquid handlers, incubators and
detectors. As new peripherals are integrated to a core
robotics system, new opportunities and higher productiv-
ity are realized. The key to successful progress in robotic-
based automation is the perception and utilization of the
core robotic communications and operating systems as an
infrastructure upon which all workstation interfaces are
developed. In practical terms it is necessary to answer
three questions when interfacing a new device. (1) Can
the device be made compatible with the dexterity of
the robotic arm? (2)Is it possible to communicate with
the device using standard protocols consistent with the
existing robotic operations and scheduling architecture?
(3) Are the benefits derived from interfacing the device
significant? As the three questions imply, a robotic arm
will only become an infrastructure tbr future develop-
ment and success if it is part of an open architecture
which supports expansion both physically and operation-
ally.
High throughput screening for novel lead com-
pounds using defined biochemical assays
Berta Strulovici and Sarkiz Daniel-Issakani
Tularik Inc., S. San Francisco, CA, USA
The approach Tularik has taken to the discovery ofnovel
lead compounds is the screening of hundreds and thou-
sands of test materials from various sources against a
diversity of biochemical assays in robotic format. This is
achieved by integrating the organization of the test
compound library with a relational database, the devel-
opment of biochemical assays in a robotic-friendly format
and high throughput screening. Particular attention is
being paid to the use of automation in all aspects of the
drug discovery operation.
To ensure structural diversity, Tularik has assembled a
large library consisting ofcompounds ofknown structure,
and natural product extracts from various sources such as
microbial, plant and marine extracts. To fulfil immediate
screening requirements and at the same time ensure
longevity, our libraries are aliquoted in replicate 96 well
plates. All compound information is electronically up-
loaded into a relational database.
Automated data analysis software has been created,
which is based on the 4D program for Macintosh, to
handle the vast amount of data generated. This is a
relationally integrated custom application. The data
from robotic screening is electronically uploaded, and
so are the follow up results. Virtually every endpoint 96
well reader exports data in a different format. A driver
was designed for each detection system to convert raw
plate data to a single format for analysis. The database
flags the ’hits’ for quick recognition and generates
comparative reports.
The targets in which Tularik is interested are novel.
Therefore, a major challenge is the design of biochemi-
cally sound, valid assays, the ability to automate them
and implement screening expediently. At present, several
types of assays are running simultaneously in robotic
format: protein kinases, a variety of enzymes involved
in gene replication, protein/peptide interaction assays,
and protein/DNA interaction assays. The assays are fully
automated using Zymark robotic systems on which we
integrate and customize all the hardware and software
required by the assay flow chart. This includes the
integration of one or two different detection systems such
as a luminometer, fluorescence spectrophotometer on the
same robotic system. Using these systems, a throughput
of 1-2 million data points per year is achieved.
Management of a centralized high throughput
screening facility
Mark D. Lister
Sphinx Pharmaceuticals, Durham, NC, USA
High throughput screening programs have seen a resur-
gence as the preferred method for lead generation in drug
discovery. Due to recent technological advances, such as
liquid handling automation, assay miniaturization and
imaging plate readers, the length of time to run a screen
on any given target has gone from years to a few months
or weeks. There are two prominent approaches to screen-
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ing: a single centralized laboratory or a number of
decentralized laboratories, often divided by therapeutic
areas. Through its acquisition of Sphinx Pharmaceuti-
cals, Eli Lilly and Company has established a centralized
screening approach to its drug discovery program. In the
past, screens were run by personnel trained to do a
specific task where little or no scientific foundation was
necessary. The present paradigm requires personnel with
higher skill levels. These include a solid background in
biology, an aptitude for automation and computers, and
an ability to work in a team atmosphere. The operations
group at Sphinx consists of 10 people who run, over the
course of the year, 15 or more screens of all types (i.e.,
receptor, enzymatic, cellular, etc.). Methodologies em-
ployed range from semi- to fully-automated. Along with
validating the automation and running the screen at high
volume, managing screen operations involves input on
technical feasibility of assay protocols of upcoming
screens. Furthermore, it is necessary to continually seek
out new technologies that will not only increase throughput
but increase the probability offinding good drug candidates.
The versatile TPW llmfrom powder to liquids
Simon Smith
SmithKline Beecham Pharmaceuticals, Crawley, UK
Following on from the success of two BenchMate Table
Processing Workstations, the TPW II laboratory up-
grade programme was developed and executed with the
omission of any instrument downtime. The existing two
systems have been replaced with two TPW II systems
and a third was purchased primarily to support new
product introductions.
The main justification for the purchase of the TPW II
was for the analyses of powders, namely compression
mixes during the quantification of the manufacturing
process. The notion that liquid samples, for example
viscous syrups, could be analysed using the quantitative
powder handling module did not occur until after
installation. The powder module was extensively tested
within our laboratory environment during Zymark’s beta
testing programme. The experience gained here and also
subsequent development validation efforts was described
in this paper.
Several key automated analytical method validation
routines have been developed for the TPW II encom-
passing all types of product formulations. This has aided
the development of automated methods both within the
laboratory and the R&D environment where the major-
ity of method development and validation occurs before
transfer to the Crawley New Production Introduction
facility.
Segmented automation techniques in a develop-
ment environment
Harnath Doddapaneni, Nagesh Palepu and
John Jushchyshyn
SmithKline Beecham Pharmaceuticals, Upper Merion, PA, USA
SmithKline Beecham Pharmaceuticals currently enjoys a
large pipeline of commercializable compounds, as these
compounds move to formulation selection and phase III
testing the analytical efforts to produce data in a GMP
manner tax the capacity of manual instrumentation.
Automation presents a challenge because of the diversity
of compounds, the unique requirements, and the level of
training within each development team.
A flexible approach to automated dissolution was pre-
sented, which employs segmented workstations and a
Zymark dissolution device ofother automated dissolution
samplers. Each dosage unit under development employs
only those stations required for the task, each station is
easy to use or program and requires little training.
Stations not in use for the dosage unit under investigation
are free to perform other tasks. Strategies to increase
throughput and assure quality of the Zymark dissolution
device were described. Data collection and automated
reporting of non-routine dosage testing were discussed.
Automated dissolution testing using the Zymark
Multidose
Joseph L. Schmitt, Ruben Lozano, Steve Conder
and John M. Joseph
Bristol-Myers Squibb Company, New Brunswick, NJ, USA
The Zymark MultiDose is a non-robotic dissolution
workstation for the automation of USP Apparatus 2
(paddle) dissolution profiles. MultiDose can automate
up to eight standard 6-vessel dissolution tests without
operator assistance. Analysis can be performed using on-
line UV or off-line by HPLC.
MultiDose frees up analyst’s time by automating crucial
steps in dissolution testing such as; media sparging (using
helium), preheating and dispensing into two vessels;
verification of vessel temperature; dropping of dosage
forms (either in batch mode ’all at the same time’ or
serial mode ’one at a time’); collection and filtration of
sample aliquots at prescribed times; and cleaning of
vessels at the end of the test. These steps can be repeated
for up to eight batches of tablets.
Automated dissolution testing in pharmaceutical
development
Christine Hecht
F. Homann-La Roche Ltd, Basel, Switzerland
Requirements regarding time to market, cost effective-
ness and cGMP compliance in pharmaceutical develop-
ment have dramatically increased in the last few years
and will continue to do so. This means, among other
things, that different dosage forms, dosage strengths and
packaging configurations of a new drug product are to be
developed in parallel and before efficacy and dose range
have been finally established.
One of the most important aspects in the characterization
of a new drug product is its dissolution behaviour. Multi-
point dissolution profiles are consistently required for
release and stability testing throughout the whole devel-
opment. Together with the increased number of samples
and the time and cost constraints, this means that the
automation of dissolution testing is mandatory for most
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analytical laboratories working in the field of pharma-
ceutical development.
For the above reasons, a Zymate System with the
capability to perform fully automated dissolution testing
of solid oral dosage forms using USP Apparatus or 2
including online spectrophotometric or HPLC assay of
the samples has been installed in the area ofDevelopment
Products Analytics of the Pharmaceutical Quality Con-
trol and Assurance Department of F. Hoffmann-La
Roche Ltd. This presentation described technical design,
operational environment, validation and practical ex-
perience acquired in routine operation of the Zymate
Dissolution System.
Ten years of robotics and laboratory automation
in a production control laboratory
Julius Brown
Eastman Chemical Company, Columbia, SC, USA
Carolina Eastman Division (CED) of Eastman Chemical
Company produces polyethylene terephthalate (PET) at
the world largest single site PET production facility
located in Columbia, South Carolina. CED Polymers
Laboratory operates 24 hours per day performing analy-
tical testing of products and process samples for monitor-
ing production processes. The laboratory analyses an
average of 1800 samples per day (> 3800 results) using
a variety of analytical techniques. Because most results
are used by process operators in real-time to control or
monitor processes, most samples are processed through
the laboratory in to 4 hours. In order to meet the
demands for efficient, accurate, and timely testing CED
has operated Zymark Robots and other laboratory
automation since 1986. These systems are operated 24
hours a day seven days a week. CED has realized gains in
labour efficiency, as well as reduced exposure to noxious
chemicals through the use of automation. The robot
systems have evolved from Zymate I to Zymate II to
XP Robots with System V controllers. The robots per-
form sample preparations for different product analyses
and are interfaced to an MIS system for automatic data
reporting resulting in completely automated analyses.
This presentation described robot and other automated
applications, the evolutionary process for their improve-
ments, and discussed the benefits and challenges to
implementing and maintaining these systems.
Management’s view of the design, construction
and installation of a custom robotic system
V. E. Clay, P. Y. Yen and S. L. Widmer
Bayer Corporation, Stilwell, KS, USA
The Environmental Fate Team at Bayer Corporation
Agriculture Division is responsible for the development of
pesticide residue methods and the annual analysis of
thousands of soil and water samples. Unique residue
methods are required for each active ingredient and its
major environmental degradates. The methods must
provide separate quantitation of each analyte in the
part-per-billion to sub-part-per-billion range. Samples
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from EPA-mandated soil dissipation and ground water
monitoring studies must be analysed promptly and
efficiently. To meet shortened product development
schedules without increasing staffing, custom robotics
systems were purchased.
The conflicting needs of a high throughput for efficient
sample analysis and adaptability for yet-to-be developed
residue methods led to the initial design and construction
of a functional, but unreliable robotic system. Using a
’Win-Win’ approach, Zymark and Bayer abandoned the
initial designs, costs and deadlines and redefined all goals
and operating constraints. New robotic systems, which
are much more efficient, flexible and reliable, have been
constructed and installed. It is believed that the rede-
signed systems, with updates and modifications, will play
an important role in the soil and water analysis method
development work for many years to come.
Versatility--the key for success of automation
systems in research & development laboratories
Ramasamy Tamilarasan, Paul L. Morabito,
John J. Zieman and P. D. Hazelwood
The Dow Chemical Company, Midland, MI, USA
Research and development (R&D) laboratories and
Quality Control (QC) laboratory represents contrasting
paradigms of operation with different modes of success
for automation systems. QC laboratories typically have
large numbers of similar samples to be analysed using
well defined procedures, and thus high sample through-
put is the major impact of automation systems. R&D
laboratories commonly have various types of samples to
analyse and analysis procedures often must be developed.
The automated system should be simple and flexible for
multiple users with several different procedures. This
presentation described such a versatile system recently
developed for preparing samples in an analytical R&D
laboratory. The system is capable of preparing samples
using seven different predefined methods and one user
configurable method. User-friendly graphical interface
provides easier data input and output.
Managing automation in an environmental testing
laboratory
Lars W. Lindquist
WMX Technology Center, Inc., Geneva, IL, USA
Today, more than ever, there is a need to automate
processes to drive costs lower while improving efficiency.
Automating projects requires careful thought and plan-
ning to obtain success. Often a project can be better
addressed if a phased in approach is used in the devel-
opment stage. One approach used at the WMX Tech-
nology Center over an eight year period to develop an
ongoing successful automation program was described.
New workstations and system enhancements were also
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The creation of an integrated data handling sys-
tem for automated organic synthesis
Chris Green
ZENECA Pharmaceutical, UK
Automated chemical synthesis, of novel chemical entities
for biological screening, has been carried out in the
author’s laboratory for four years. To undertake effective
organic synthesis on a Zymate XP Robotic system
requires a considerable amount of data manipulation.
Originally, this was a tedious process involving file
transfers to and from a VAX system. With recent PC
and network advances, software packages (Excel, Word,
Isisbase, Isisdraw, Project Library) can be run which
enable the data to be managed effectively.
Data management in the oligonucleotide synthesis
laboratory
Joel L. Boymel, Butt Goodman, Cheryl Johnson,
Brian Governski, Juli Ross-Kramer,
David Van Ausdall, Ted Jones and
William S. Marshall
Amgen Inc., Boulder, CO, USA
The DNA Technology Group at Amgen has the respon-
sibility of synthesizing the oligonucleotides necessary for
Amgen’s research needs. In the last five years the demand
for oligonucleotides has grown exponentially. From 1991
to 1994 the DNA manufacturing process changed dras-
tically. The constant state of flux made a traditional
database system too slow to respond to changing needs.
As a first iteration, it was decided that a user modifiable,
flat file system would be used. Over the next few years the
manufacturing process settled and the data system
evolved to handle the increasing load. Orders were
electronically cut and pasted from e-mail and macro
utilities were utilized to automate redundant processes.
The data system was able to adapt quickly, but quickly
became a difficult to manage conglomeration of sofware
packages from many different vendors, loosely held
together by macro tools that were stretched to their
limits. Eventually, excessive time was spent ensuring data
integrity, indicating that this system’s limits had been
reached.
In 1995 the next iterative change in the data manage-
ment system occurred. Since a workable system was in
place, an open, expandable system could be designed.
Computer platforms were chosen to best fit the authors’
situation. A client-server system was chosen to ensure
that work could be done from any location. Touch
screens and barcode scanners were used to speed the
processing of oligonucleotides. Orders were placed di-
rectly into the sytem over the network using a small
external interface, elimnating operator manipulation of
sequences. File servers are used to transfer data to and
from external robotic systems. More information is
tracked, and reported, with less operator input and error.
The only thing constant is change itself. The best we can
strive for is to manage that change as best we can. The
modularity and connectivity of the current system will
allow seamless upgrades when the need arises.
Electronic laboratory notebooks: The R&D team
computing and the needs, the systems and the
consortium
Rich Lysakowski
Team Science, Inc., Sudbury, MA, USA
An intensive, multi-company study was started in Octo-
ber 1994, called ’R&D Team Computing Study’. R&D
Team Computing Systems contain a large number of
subsystems or components, including electronic records,
management systems, electronic record keeping, project
data and document management systems, workflow,
groupware, and other types of collaboration systems.
The purpose of an R&D Team Computing System is to
foster better Collaboration of professionals working on
complex product research and development projects, in
order to greatly reduce cycle times and improve the
quality of both products and customer services.
The R&D Team Computing Study started with surveys
of hundreds of users’ needs in the pharmaceutical,
chemical, biotechnology, and materials industries, and
resulted in a master list of requirements for R&D team
computing systems for FDA--and EPA--regulated in-
dustries where patent applications are routinely filed to
obtain proprietary advantage. The next step was to
profile the most popular vendors and systems in the
marketplace, based on demand and priorities set by
users. Finally, a multi-volume report was written that
outlines the background for the business, regulatory,
legal, technical, and social needs, the profiles of fit for
various vendors and systems, along with summaries for
various levels of management and end users.
The R&D Team Computing Study represents the culmi-
nation of several years ofwork to understand and specify
the broad range of requirements of global, collaborative
electronic notebook systems, which operate at the inter-
section oflaw, commerce, sociology, science, and technol-
ogy. The results of the study pave the way for better
integrated systems to be built that significantly enhance
global collaboration on complex R&D projects, while
addressing the needs for reliable and trustworthy record
keeping and records management.
This presentation described the results from this compre-
hensive study including: the needs survey; vendor tech-
nology profiling project; bottom-line results; and the
R&D team computing consortium.
Increasing analytical laboratory productivity by
simplifying complex processes
Richard G. Poser
Dura Pharmaceuticals, San Diego, CA, USA
Process re-engineering has become the fashion. As com-
panies are compelled to do more with less, they have
turned to the science of re-engineering in the hope of
enhancing the productivity of their precious remaining
resources. Research, development and production facil-
ities have become more efficient and productive by
implementing new technologies. Regulatory require-
ments demand additional testing in support of stability,
cleaning and validation programs. These factors have
created tremendous new demands on the analytical
77Abstracts of papers presented at the 1996 ISLAR
testing and control laboratories that support these opera-
tions. Lab managers with limited resources constantly
face increasing workloads, shorter deadlines, and a
demand for more rapid sample turnaround.
It is a common oversimplification to equate laboratory
re-engineering with introducing automation. Re-enginer-
ing is about improving efficiency and productivity of a
system. While re-engineering analysts frequently recom-
mend automating a manual process, automation is only
one of several solutions a skilled system analyst may
utilize to improve the productivity of a system.
Re-engineering should begin with a thorough analysis of
the process, paying particular attention to how work and
information flow through the system. This may reveal
redundant, archaic or unnecessary steps that can be
simplified or eliminated. Only after the system is simpli-
fied as far as possible should automation then be con-
sidered, and only then if further gains are cost effective.
A case study was presented, showing how an analytical
support laboratory was able to permanently increase
testing capacity and improve test quality while reducing
average sample turnaround from 60 to four days. This
was achieved following a thorough process analysis that
revealed how data flow could be simplified, delegation of
sampling responsibility and sequential testing to elim-
inate unnecessary testing. A second case study illustrated
how process analysis and simplification accelerate docu-
ment review and approval prior to automation of a
regulatory document routine system.
The role of automated systems in laboratory re-
engineering
Michael L. Rutherford
Eli Lilly and Company, Indianapolis, IN, USA
As more and more emphasis is being placed on improving
laboratory efficiency in order to provide more analytical
data at reduced costs, provide higher levels of customer
service, and generate more timely results, many labora-
tories are forced to change how they are doing business.
Re-engineering the workflow of the laboratory by reor-
ganizing the functional group is one approach to this
situation. This approach can provide better focus, ded-
ication of resources, improved customer service, and
reduced cycle times. However, this approach often does
not reduce resource requirements and costs since some
replication is necessary to meet the customer service
requirements. For years, robotics and automated work-
stations have been utilized to improve staff utilization, as
well as improve the quality of results. Incorporating
automated systems into the workflow improvements can
provide even greater benefits in many cases, whether part
of the original re-engineering process, or as further
enhancement to the plan. To demonstrate the benefits
of incorporating automated systems in the re-engineer-
ing process, several scenarios within Eli Lilly were
presented.
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Meeting a client’s needs using a Zymark Multi-
dose in a contract laboratory setting
Timothy D. Rhines
BAS Analytics, West Lafayette, IN, USA
BAS Analytics, a contract laboratory for the pharmaceu-
tical industry, was challenged by a client to perform a
large scale stability program. Each method required two
sample pulls and two dilutions before injection into an
HPLC. At the time the project was presented, BAS
Analytics had two manual dissolution units. The pro-
gram required potency, dissolution, TLC impurity
screening, tablet hardness, tablet thickness, and moisture.
Through the multiples of tablet potencies and packagings
a total of 96 samples were set on stability. The task facing
BAS Analytics was how to complete the required dissolu-
tion work for the three-month stability time point within
a three week testing window. This stability protocol
requires two dissolution methods to be performed. Pre-
viously, most of the work was done manually. BAS
Analytics identified that automation was the best means
for growth, without adding excessive staff. Zymark was
contacted in late April of 1995 and an order was placed
with them for a MultiDose Automated Dissolution Work-
station, and a BenchMate II. Instrument performance
validation of the systems was performed in June, as was
the automated method validation. BAS Analytics was
ready to test the samples when they arrived. The co-
operative effort between Zymark, the client, and BAS
Analytics resulted in data delivered on time for submis-
sion. The validation process, time schedule, issues and
benefits experienced at BAS Analytics were discussed.
Rosie the robot. Laboratory automation during
the war years, 1941 to 1945
Kevin Olsen
Wyeth-Ayerst/Lederle Labs, Pearl River, NY, USA
In our own day, managers often cite the gains in
productivity as the primary reason to automate labora-
tory operations. This is hardly new. During the Second
World War, shortages of skilled labour and materials
were felt in the chemistry laboratory. Doing more with
less was not a matter of corporate policy, it was a matter
of national survival.
An amazing variety of automated devices were created
between 1941 and 1945. Some were designed to save
labour, such as the automated distillation units seen in
the petroleum industry or other organic chemistry la-
boratories. Certain automatic titrators, polographs, re-
cording instruments and water still also fall into this
category. Other equipment was intended to conserve
strategic materials, like an all-glass constant-rate reagent
addition device, specialized control relays and a constant
temperature bath that was made out of a lamp globe,
thermostat, and heating device, all for less than four
dollars. Still others improved assay performance by
automating steps that were prone to human error.
Although the technology has changed, the reasons to
automate have not. These devices were largely con-
structed by end users who were working alone. This fact
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important ingredient in automation is not the hardware,
it is the imagination.
Solid phase extraction of antidepressants from
mouse, rat and human plasma utilizing robotic
workstations
Patrick J. Faustiano, Christopher D. Ellison and
Karl P. Flora
U.S. Food & Drug Administration, Laurel, MD, USA
Antidepressants are used clinically to treat mental illness.
Their widespread use and the large range of dosed
utilized for the treatment of depression have currently
revealed and expanded need for monitoring of plasma
drug levels because of inter-individual differences in both
steady state plasma levels and metabolism. Drug mon-
itoring of patients undergoing long-term treatment with
antidepressants may provide a more accurate determina-
toin of an individual’s appropriate therapeutic dose.
Recent FDA studies required monitoring antidepressant
plasma drug levels in rodents for pharmacokinetics
scaling to humans. Automated methods that are repro-
ducible and accurate have proved essential for the
preparation of large numbers of pre-clinical and clinical
samples.
The authors have developed and evaluated automated
solid phase extraction methods for two antidepressant
compounds and their pharmacological active metabolites
from plasma: a first generation tricyclic antidepressant,
amitriptyline, and a second generation selective from
mouse, rat and human plasma using BenchMate robotic
workstations. Plasma drug levels, pharmacokinetics and
metabolism of relevant clinical doses from native and
chronically treated animals were determined by high
pressure liquid chromatography with ultra-violet detec-
tion. Robotic workstations now occupy a central role in
the rapid development of automated methods for the
preparation of bioanalytical samples.
Microlute a semi-automated solid phase extrac-
tion system in the 96 well format
R. A. Biddlecombe and S. Pleasance
Glaxo Wellcome, Beckenham, UK
The use of liquid chromatography tandem mass spectro-
metry (LC-MS-MS) in quantitative bioanalysis, with
analysis times typically less than 4 min, has made sample
preparation the rate determining step, particularly when
using solid phase extraction (SPE). The use ofSPE in the
96 well format, coupled with a Packard Multiprobe
robotic sample processor (RSP), allows rapid processing
of samples in the batch mode. A modified vacuum
manifold positioned on the deck of the Multiprobe is
used to control the flow rate of the liquids through the
block. The Multiprobe is used to prime, load, wash and
elute the blocks. After each step, a post run customized
program activates the vacuum by switching a valve. The
RSP aspirates sample, buffer and internal standard
sequentially and adds them to the block, the dispensing
speed giving adequate mixing. The placement of the
collecting plate in the vacuum manifold, prior to the
elution step is the only manual intervention required.
A modified HPLC autosampler (Gilson 233) is used to
inject samples directly from the collection plates. The
autosampler has a capacity of six blocks which even with
a 2 min run time allows around the clock operation ofPE
Sciex API-III mass spectrometer.
This approach offers many advantages, speed (96
samples in approximately 50min), no manual liquid
handling, no vial capping or labelling and true high
throughput quantitative mass spectrometry (sequential
injection of up to 576 samples). The format has also
proved amenable to different packing materials and
packing volumes. A strategy for the complete automation
of the system using a Zymark robot was also outlined.
Design and evaluation of an automated solid-
phase extraction method-development system for
use with biological fluids
Tresavon D. Parker III, D. Scott Wright and
David T. Rossi
Parke-Davis Pharmaceutical Research, Ann Arbor, MI, USA
An automated solid-phase extraction method develop-
ment system, utilizing a Zymate XP robot and a custom-
designed solid-phase extraction (SPE) manifold, has been
developed and validated. This system spikes blank liquid
matrix, such as plasma serum or urine, with solutions
containing drug, internal standard, and up to two
metabolites. Samples are then buffered or diluted with
an appropriate reagent. After these samples and corre-
sponding blanks have been prepared, solid-phase car-
tridges containing selected sorbents are automatically
conditioned. Samples are robotically vortexed and trans-
ferred to the conditioned cartridges, and analytes are
extracted. Validation of this robotic system demonstrated
acceptable precision and accuracy for two types of liquid
transfer including metering pump (< 6%RSD and RE
for > 2"0ml dispensation), syringe-based laboratory sta-
tion (< 2-9%RSD and 0"5%RE for volumes between
0-25 and 1.00ml and syringe hands (< I%RSD and RE
for volumes between 0"25 and l’00ml). For two model
compounds (CI-988 and PD 135158), the system effec-
tively distinguished good solid-phase sorbents from mar-
ginal ones through precision, recovery and
chromatographic selectivity. Solid-phase extraction of
these compounds from human plasma gave precision
(2% to 4%RSD) and extraction efficiency (96 +6%)
comparable to results obtained from manual extractions
(92 + 11%).
Use of the Rapid TraceTM SPE workstation for
accelerated methods development
Xialoi Ren and Allan Witkowski
BAS Analytics, West Lafayette, IN, USA
Due to its high throughput and ability to process samples
unattended, automated solid phase extraction (SPE)
should enable accelerated methods development for
analytes in biological matrices. To explore this possibility
further, a generalized approach to SPE methods devel-
opment was designed and implemented using the Rapid
Trace Workstation. The model beings with pre-develop-
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ment groundwork, leading to an initial extraction meth-
od. The methods development phase is broken down into
two portions, extraction optimization and time reduc-
tion. The automated variation of key variables (such as
sorbent material and bed size, solvents, pH, volumes,
speed, etc.) allows for a comprehensive range of para-
meters to be quickly evaluated. Finally, the optimized
method is used to perform a full method validation. This
experimental approach is illustrated through the devel-
opment of an automated SPE assay for proprietary drug
in human serum, focusing on the rational behind the
methodology, the impact on assay ruggedness, and time
savings achieved.
Managing compound library production through
modular automated workstation-based system
James B. Campbell and Richard A. Wildonger
Zeneca Pharmaceuticals, Inc., Wilmington, DE, USA
The advent of combinatorial libraries has infused the
pharmaceutical industry with a novel set of tools to
expedite drug discovery. Thus, parallel methods of
synthesis and combinatorial, or mixture synthesis,
coupled with high-throughput screening have greatly
enhanced capabilities in identifying novel drug candi-
dates of higher quality, and with greater rapidity, than
ever before. Automation is central to the efficient im-
plementation ofcompound library synthesis. The authors
described some of their initiatives to develop compound
library production systems for managing the numerous
processes involved in high through-put chemical syn-
thesis. Single and multi-tasking automated modules can
systematize and increase the efficiency of the various
processes which provide the framework of chemical
library synthesis system. Thus, modules used for reagent
preparation, barcode labelling of reagent and reaction
containers, reagent transfer modules, off-line incubation
stations and post-reaction processing stations can all be
integrated to define a library synthesis system. Progress
on implementation of such synthesis systems dedicated to
library production was reviewed.
Developing a high speed synthesis paradigmmthe
workstation approach
Butt Goodman, Kirsten Bjergarde, Joel Boymel,
Ted Jone and Larry Melvin
Amgen Inc., Boulder, CO, USA
The New Leads Discovery department at Amgen-
Boulder is responsible for the synthesis of libraries of
compounds in an automated fashion. After evaluating
commercially available synthesis automation, instrumen-
tation was developed using a ’workstation’ rather than a
’system’ approach. The key to this strategy is a modular
reaction block design that is portable between instru-
ments. Reaction block modules insure that valuable
instrument time is not tied up during reaction incubation
periods. Using this approach, several flexible worksta-
tions which perform specific functions have been devel-
oped. One workstation performs resin loading into
reaction vessels and also preparation of diversity elements
in a standard format. Another workstation is devoted to
transferring solvents and diversity elements into reaction
vessels. A third is used for solvent washing as well as
cleavage of compounds from solid supports. A separate
heat/shake/cooling incubator is used for reaction incuba-
tion. To complement these systems, off-the-shelf compo-
nents such as TurboVaps and speedvacs have been
modified to support downstream sample processing.
The function and performance of these workstations
was examined.
ACID for the Tecan: an automated combinatorial
interface demonstration
Robert M. Kennedy
Parke-Davis Pharmaceutical Research, Ann Arbor, MI, USA
Automated liquid handling workstations for performing
combinatorial organic synthesis are recent additions to
the organic laboratory. Many of these robots are mod-
ifications of those used for biological work. Much of the
recent literature describing these newly developed ma-
chines has focused on hardware.
Described in this presentation was a software suite,
ACID, which was developed for the Tecan. This software
arose from a need to simplify a typical organic chemist’s
interaction with the liquid handling robots performing
parallel synthesis. Prior to this, much of the available
software had been designed for biological work in which
most samples are treated identically. It is the definition of
combinatorial work that all samples are treated differ-
ently, hence a new approach was needed.
The 20 programs written for ACID consist of four basic
groups: Reactions, Extractions, Chromatography and
Archival. The user launches a program within Integrator
and is presented with a series of menus specific to that
program. This program then creates a command file.
ACID then uses a single program. This program then
creates a command file. ACID then uses a single program
to read and interpret the command file for the Tecan. In
the course of the execution of this program a log file and
an error file are generated. Programs executing reactions
also generate a tag file which describes the synthetic
history of well locations. The tag file provides the links
to the SD file containing structures.
A fully automated stacking microplate lumino-
meter for high throughput screening
Steven Lenz, Ed Marples and Mel Reichman
Ligand Pharmaceuticals Inc., San Diego, CA, USA
The Torcon Stacking Luminometer incorporates a Dy-
natech ML 1000 luminometer, reagent dispenser, com-
puter, barcode reader and a plate stacking/shuttle device
equipped with a mechanical gripper. The system is
capable of reading stacks of up to 25 plates with a three
fold increase in detection sensitivity. A plate is removed
from the stack, placed on the plate shuttle and its barcode
is read. The shuttle positions the plate under the reagent
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addition station, which is capable of dispensing between
10 and 300 gl of reagent. After reagent addition, the plate
is shuttled to the luminometer loading position, where a
robotic hand grips the plate and places it into the
luminometer. The plate is read and the data analysed
for out of range messages. If any are found, the gain is
automatically adjusted and the plate read with the new
gain. After the data is acquired the plate is placed into
the output stack. The barcode on the plate is encoded
with a unique identifier for storing the data and the
default gain setting to be used by the luminometer. Data
is written locally, then automatically uploaded to Oracle
at the end of the run. The system failure rate is 0"1% of
the plates processed and costs under $40K. ICN’s plate
stack magazines are used by the Torcon and can be
interchanged with the stacking reader and platewasher
devices used in the lab. This system will be modified for
use with a CRS Robotics arm as part of a plate stacking
robot system.
Transferring and validating a biochemical assay
into a high throughput screening assay
Richard Harrison
Rhone Poulenc Rorer, Collegeville, PA, USA
The drug discovery process is a multi-discipline, multi-
faceted operation utilizing expertise from scientific back-
grounds as diverse as genetics and chemistry. The process
begins as biologists and geneticists discover new pathways
and targets. Next, chemists synthesize small molecule
inhibitors, agonists, or antagonists of these define targets.
Finally, biologists and pharmacologists test these com-
pounds in animal models for in vivo efficacy. Each step in
the process is a transfer of information and technology
from one scientific discipline to another. However, the
process is a slow one, typically taking up to 10 years to
identify and market a new drug entity. Historically, the
slow step in the drug discovery process has been collect-
ing and synthesizing compounds as potential drug candi-
dates. With the advent of high speed parallel synthesis, a
vast array of chemically diverse structures, previously
unattainable, are created daily for biological character-
ization. Now, the slow step in the process becomes
the characterization of compounds through biological
assays.
Biological assays are generally crude systems designed to
understand the workings of a protein or receptor, and for
its initial characterization and purification. Such assays
are inherently laborious, time consuming tests not gen-
erally suitable for screening a large number ofcompound
variables such as cost reagent availability, reliability,
limits of detection, and speed are not of paramount
importance. Yet, these are the most important variables
when designing a high throughput screening assay. It is
therefore necessary to modify existing biological assays to
fit in a high throughput environment. Still, no rules exist
to guide this modification. This presentation focused on
the steps used to transfer biological assays into a high
throughput environment. The choice of assay, kinetic
and thermodynamic characterization of the reagents, and
assay validation were discussed. Examples of situations
from the pharmaceutical industry were presented.
Establishing a high throughput screening core
group at Procter & Gamble Pharmaceuticals
Jonathan Cook, Barbara Hynd,
Barbara Kozikowski, Kathy Rasmusen,
Deborah Paugh, Julie Whitten, Jennifer Sway
Procter & Gamble Pharmaceuticals, Cincinnati, OH, USA
Scott Atkin, Tim Bruemmer and Bryan Wildman
Sagian Incorporated, Indianapolis, IN, USA
About two years ago the authors started assembling a
screening group at Procter & Gamble Pharmaceuticals.
The process was completed quickly and efficiently, and
the group did not affect overall head count, although
some personnel re-assignments occurred. In order to
accomplish this, all expertise gaps in automation, data-
base management, and screening facility operation have
been filled through contracts and by consultation with
recognized leaders. Automated compound dissolution
and distribution, and a capability for both cell-based
and biochemical assays are now in place. The group,
located with the compound repository as one of its
primary customers, has integrated software and tracking
systems. Handling the high volume of data generated by
HTS, associating results with the correct compound and
integrating with company databases has been accom-
plished using CSAPTM from MLT Automation. The
process of identifying and implementing the key compo-
nents of the core facility formed the basis of this presenta-
tion.
Use of a two armed Zymark robot for high
throughput screening
Mark Beggs
ZENECA Pharmaceuticals, Macclesfield, UK
High throughput screening is a key component of the
pharmaceutical lead identification process at ZENECA.
Robotic systems have been employed throughout the
industry to perform the initial compound dilution and
distribution processes that form a common front end to
many high throughput screens, and the assay assembly
and signal detection steps that comprise an individual
screen. Although the use of manipulative arm system in
formulating and replicating test compounds is well
established, robotic throughput rates have been signifi-
cantly slower than those which can be maintained by
human operatives and consequently the use of robots for
performing assays has been limited. Over recent years the
industry has experienced significant increases in the rate
of compound screening and throughput rates are now
approaching the upper limit that human operatives can
be expected to achieve in a working day. To permit
future increases in the rate of screening, a novel automa-
tion system was designed based on the use of two Zymark
arms. The rationale behind automation of the screening
process, the capabilities provided by the system and the
resulting benefits were described.
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Automated high throughput screening to aid the
drug hunter at GlaxoWellcome
M. N. Banks, S. Fogarty, M. Valler, K. Mills,
S. O’Brien, A. Binnie and J. G. Houston
Glaxo Wellcome, Stevenage, UK
Lead discovery within drug discovery at GlaxoWell-
come’s Medicines Research Centre plays a key role in
the company’s high throughput screening programme.
This presentation described how automation has been
used to facilitate this programme and the various ap-
proaches used. High throughput screening involves the
testing of a range of different chemical entities in
biochemical assays. Typically, these samples include
single entity compounds, combinatorial compound li-
braries and partially or fully characterized natural
products. The storage and preparation of these materials
are performed by the Compound Diversity Unit and
microtitre plates are provided for automated screening.
For the last two years a Robolab 9600 has been used, and
recently a second screening system has been commis-
sioned that will dramatically increase our high through-
put screening capacity. This second system, R2, contains
two robotic cells, one for performing isotopic assays and
the second for non-isotopic work. This presentation
described how this system was designed, built and
commissioned to run on both 96 and 384 well microtitre
plates.
Developing smart robotic stations with embedded
controllers
Stephen Dokoupil
Helen Curtis, Inc., Rolling Meadows, IL, USA
Often there is a need for the addition of extra sensors or
control in a robotic station. At the same time the I/O
available through the Zymate Power & Event Controller
may be exhausted by existing system complexity. The use
of simple embedded controllers or small single board
computers can help expand the I/O capabilities of the
robot system. A basic overview of embedded controllers
was presented. This included the different types of
controllers currently available, their cost and their use
in a typical robotics or instrument application. Basic
interfacing techniques and programming the controller
were also covered.
Creating reusable instrument objects with Visual
Basic
Martin Echols
SmithKline Beecham, Inc., King of Prussia, PA, USA
and Mark F. Russo
Bristol-Myers Squibb, Princeton, NJ, USA
The relatively new object-oriented programming (OOP)
paradigm has had a dramatic impact on software devel-
opment. Yet, few examples ofOOP applied to laboratory
automation exist. Visual Basic 4.0 now supports many
elements of OOP through the creation of objects. An
object is a simple mechanism for encapsulating the
properties and functions of a discrete software entity.
The OOP approach can result in many benefits, includ-
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ing: an ability to easily reuse software modules, better
debugging capabilities, and increased robustness.
Making use ofOOP concepts for the development of an
interface to a laboratory instrument is appealing. This
’instrument’ object can be saved and easily re-used by
other laboratory software applications. In this paper the
authors discussed methods for creating objects for data
acquisition and instrument control in Visual Basic 4.0.
Strategies for managing and re-using user created instru-
ment objects were presented, which enabled the creation
of an instrument object library
An additional step in the development of a library of
instrument objects is to reformat them as OLE (Object
Linking and Embedding) objects. OLE is the foundation
of the ’plug and play’ concept that is currently popular in
the computing industry. Methods for creating OLE
objects from a library of instrument objects were also
discussed.
Visual basic applications in a laboratory environ-
ment
Juan Cadavid and Marie Sabo
Clairol, Inc., Stamford, CT, USA
In the last several years there has been a strong emphasis
on doing things more efficiently. To accomplish this
objective, the analytical group has been searching for
productivity enhancement tools to apply in a laboratory
environment. Small computer programs written in Vi-
sual Basic have been found to be one of those tools. These
programs take advantage of the many capabilities of
Visual Basic, especially its ability to create intuitive
graphical user interfaces. One of the applications im-
plemented was a program which predicts the final result
of a titration based on the theoretical contributions of the
different raw materials in a consumer product. This
program is intuitive enough that the formulators can
use it independently of their computer skills. The theore-
tical value obtained can also be used to verify the validity
of the experimental results and to develop finished
product specifications. Another important application
implemented is capturing the data coming from a
titration system and storing it in a database utilizing
Visual Basic as the front end interface. This program
allows the data to be reviewed at any time after the
sample has been analysed.
The trials and tribulations of writing these computer
programs were presented, as was the resulting impact of
productivity.
Reaction screening and optimization in chemical
process research and development
Barbara M. Ciaramella
Bristol-Myers Squibb Pharmaceutical Research Institute, New
Brunswick, NJ, USA
The shortening ofdrug development timelines has caused
pharmaceutical companies to rethink their strategies for
product development. One facet of Bristol-Myers
Squibb’s approach has been to incorporate robotics and
automation into new discovery and development para-Abstracts of papers presented at the 1996 ISLAR
digms. Within the Process Research and Development
department of Pharmaceutical Development, a robotic
apparatus has been configured to run and monitor up to
16 reactions simultaneously, enabling faster data regen-
eration and reaction assessment, including route scouting
and reaction optimization. This presentation discussed
the hardware and custom software configuration and
presented results to date.
New approaches for material handling at Glaxo
Wellcome
Brenda Johnson Ray
GlaxoWellcome Inc., Research Triangle Park, NC, USA
Chemical sample dispensing at GlaxoWellcome has
undergone a major shift in recent years. Previously, solid
sample weighing was one of the major functions of the
Materials Management group, which has responsibility
for the distribution of samples for discovery research.
Now, high-throughput screening and combinatorial
chemistry programs have been developed in order to
synthesize and test more compounds, find better leads,
and ultimately get a drug on to the market in less time.
Consequently, the Materials Management Group has
had to re-evaluate its role. First, the solid sample
weighing bottleneck was eased with the routine provision
of samples in liquid format. Next, repetitive manual steps
were automated with stand-alone instrumentation or just
simple changes in work practices. Finally, the Group
evaluated options for linking the old solid handling
practices to the new liquid handling procedures in order
to transition smoothly from one to the other. The benefits
and the process were described.
Recent applications
analysis protocols
of accelerated structure
Edward H. Kerns, Kevin J. Volks, Jeff L. Whitney,
Robyn A. Rourick
Bristol-Myers Squibb Pharmaceutical Research Institute, Wall-
ingf ord, CT, USA
Mark E. Hail and Mike S. Lee
Bristol-Myers Squibb Pharmaceuticals
Princeton, NJ, USA
Research Institute,
Current trends in product research and development
have focused on accelerated cycles (for example, pre-
clinical development) and increased sample generation
(for example, combinatorial chemistry). At the same
time, resources for internal support of these initiatives
using traditional paradigms have not increased at the
same rate, leading to the necessity for a new paradigm. In
this environment, mass spectrometry is the emerging
analytical technology for meeting current and future
needs, based on its sensitivity, selectivity, universal
applicability, speed and cost-effectiveness. Integration
of advanced mass spectrometry technology, development
ofnew methodology and novel implementation strategies
have provided increased levels of support and informa-
tion generation consistent with current and future trends.
These strategies, once developed, have been automated
for optimum productivity. This presentation described
recent development in structure characterization using
molecular weight determination and in structure elucida-
tion using LC/MS techniques. The role of standard
methods, template structure analysis, predictive profiles,
structure profile libraries and candidate analytical pro-
files were discussed. These were illustrated with recent
applications from candidate proof of structure, combina-
torial chemistry, natural product discovery, drug meta-
bolism, impurities, and degradation products.
An automated system for the purification of com-
binatorial libraries by semi-preparative HPLC
Christopher E. Kibbey, Greg A. Robertson,
Alasdair MacDonald and Sheila H. DeWitt
Parke-Davis Pharmaceutical Research, Ann Arbor, MI, USA
Combinatorial chemistry has emerged as a powerful tool
for the rapid generation of new pharmaceutical candi-
dates. Improvements in laboratory robotics and informa-
tion management systems have contributed to the field’s
rapid growth. While several systems are available for
performing automated compound synthesis, there are
comparatively fewer systems which automate the efficient
purification of milligram quantities of compounds from
combinatorial libraries. The high separation efficiencies
afforded by commercial packed columns and level of
automation inherent in modern liquid chromatographic
equipment make HPLC well suited to the purification of
combinatorial libraries. This presentation described an
automated, semi-preparative HPLC system designed for
the isolation of milligram quantities of single compounds
from combinatorial arrays produced using solid-phase, or
solution-phase techniques.
Purification of a sample library is performed in two
chromatographic steps. First, a portion of the crude
sample is chromatographed on an analytical-scale HPLC
column and elution of the sample components is mon-
itored by UV and mass spectrometric detection. The
chromatogram from this scouting run is then imported
into a custom program, where an intelligent peak track-
ing algorithm guides the isolation of selected product
component(s) fom the crude sample by semi-preparative
HPLC. Because positive identification ofeach component
in the crude sample may be performed via an LC/MS
scouting run, the system provides MS identification of the
product component in the crude sample prior to chro-
matographic purification the need to collect and analyse
multiple sample fractions during semi-preparative pur-
ification is eliminated. Further, the LC/MS data sets may
be used to verify failed syntheses, and thereby speed the
purification process by excluding these samples from
further processing.
The purification system is compatible with both reversed-
phase and normal-phase methods, and only requires that
the same chromatographic support be packed in both the
analytical and semi-preparative HPLC columns. Scaling
a set of analytical chromatographic conditions to their
semi-preparative equivalent is straight forward. The
chromatographic methods employed may be tailored to
meet the specifications imposed by the sample library.
This becomes especially important when dealing with
compound classes which are susceptible to hydrolysis,
thermal degradation, or transesterification.
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Integrated drug discovery: thriving on organiza-
tional and technological improvements
Peter Eckard, Juergen Delzer, Franz Emling,
Siegmund Guhl, Reinhold Janocha, Claus Markert,
Gerhard Paul, Juergen Seega and
Wolfgang Weruet
Knoll AG, BASF Pharma, Ludwigshafen, Germany
High throughput screening (HTS) has been established
as a standard technology in the drug discovery process of
BASF Pharma. With the HTS set-up presented at
ISLAR 94, the authors have screened their chemical
library in various enzyme or cell-based assays or ELISAs
on different molecular targets. As a result, promising
leads have been identified and some of these screening
assays are now in an advanced stage of preclinical
development. However, the routine use ofHTS revealed
several shortcomings which have been taken into account
in a new version of the authors’ HTS concept.
The demands on HTS have steadily been increasing over
time. The number of compounds to be tested, as well as
the number of targets to be screened, were boosted by
combinatorial chemistry and Genomics respectively. In
the decentralized HTS approach, where several labora-
tories in different units perform HTS and secondary
screening, the HTS equipment could be improved. To
match the needs resulting from these increasing demands
and time constraints, technological improvements and
organizational measures are mandatory.
The presentation described the authors’ experiences of
establishing HTS at Knoll AG and addressed the future
perspectives covered by the new concept for integrated
drug discovery (single compounds versus mixtures, prep-
aration of samples, highly integrated robotic systems,
HTS core unit versus decentralized approach and work-
ing time models).
A component based approach to laboratory auto-
mation
Mark N. Feiglin and Bruce J. Russell
Merck Research Laboratories, Rahway, NJ, USA
While laboratory automation projects have grown in
complexity, there has been a move towards using mod-
ular approaches in selecting instruments for automated
systems. Rather than using a single complex instrument
to perform a variety of tasks, a modular approach
attempts to divide the tasks among a number of specia-
lized instruments. Each instrument is often designed for a
specific role and is able to work independently of the
other instruments on a system. In this manner, the failure
of one instrument does not necessarily mean the collapse
of the entire system. A modular system also follows for
easy modifications to the system as needs change.
During the authors’ work in laboratory automation, they
have further developed this concept. In addition to using
modular instrumentation, a design has been developed
that also stresses a modular approach to software design.
In designing a modular software approach to laboratory
automation, it is important to select an operating system
that is flexible, robust, secure, and itself modular. One
such operating system is Microsoft Windows NT.
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The true pre-emptive multi-tasking provided by Win-
dows NT prevents the collapse of one piece of software
from affecting others controlling an automated system.
The built-in security features of Windows NT allow the
administrators of a robotics system to prevent the users
from accidentally deleting files and data important to the
operation of the system. Windows NT also allows a
degree of flexibility and modularity unavailable in most
operating systems. Computer hardware devices (such as
multi-port serial cards and IEEE cards) are handled by
the operating system rather than separate device drivers.
This allows for software design that is truly hardware
independent. Windows NT offers some additional bene-
fits, including a limit of 256 serial ports per computer,
remote system maintenance, and increased system re-
sources.
Designing a robotics system on an object-based operating
system allows the use of object based programming
languages to develop software tools for automation.
When defining a component in a robotics system, it can
include both the instrumentation and software required
for its operation. Object based programming languages
such as Microsoft Visual Basic 4.0 allow for a modular
approach to instrument control. The instrument control
software can also be used without the automated system.
This allows the users to become used to the look and feel
of the instruments integrated with their software drivers
in a stand alone mode. The future ofmodular laboratory
automation includes a modular software approach, as
well as modular instrumentation. The authors have
begun development of such a system and presented some
of their experiences.
High throughput screening through the use of
robotics and a high performance data handling
system
Shin-Ichi Nihira, Hiromichi Kotaki and
Atsuko Nakano
Nippon Roche Research Centre, Kamakura, Kanagawa, Japan
High throughput screening (HTS) using various auto-
mated devices including robots has expanded the cap-
abilities of random screening of natural products and
chemical libraries for drug discovery during the past
several years. It is a promising approach in the rapid
and efficient identification of compounds. The utilization
of robotics coupled with a high throughput data handling
system allows hundreds of thousands of screening samples
(natural products as well as synthetic chemical com-
pounds) to be processed in a realistic screening period.
For further improvement in performance of the entire
process of HTS, the following issues must be addressed:
logistics of assay samples; informatics; screening automa-
tion.
The authors’ group is responsible for HTS and for
implementation of HTS related technologies. During
the past few years, the screening process has been
developed to accommodate extremely large number of
samples derived from chemical compound libraries and
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This presentation focused on the authors’ practical
experience and presented some issues related to interfa-
cing of both systems.
Automation of assays for nuclear receptors
Steven G. Blanchard, Cole O. Harris,
James S. Nichols and Derek J. Parks
GlaxoWellcome Inc., Research Triangle Park, jVC, USA
The development and automation of functional and
ligand binding assays for members of the steroid/thyroid
superfamily of nuclear hormone receptors was described.
The use ofstand-alone instrumentation and assay stream-
lining allowed for rapid automation without any result-
ing delay. The assay formats utilized are generic and
have been verified for multiple nuclear receptors. As a
result, implementation of additional assays for members
of the nuclear receptor superfamily can be accomplished
with minimal assay development.
Implementation of the TPW II Powder Pouring
Workstation for on-line analysis of process valida-
tion samples
Thomas D. Groeschner
Schein Pharmaceutical, Inc., Carmel, NY, USA
The current analysis of process validation samples by
current manual analytical procedures has demonstrated
the need for automation due to the large sample load and
the labour intensive nature of the manual preparation
procedure. At Schein Pharmaceutical, the idea of auto-
mating the procedures to analyse process validation
samples (powdered samples) was taken to Zymark
Corporation. In conjunction with Schein Pharmaceuti-
cal, a TPW II workstation was developed to handle all
the parameters required to process powdered process
validation samples.
Schein demonstrated automation for a number of rea-
sons. First, the FDA requires that all of the contents of a
process validation sample be analysed. To accomplish
this manually, the bottle must first be weighed, the
contents of a bottle must then be emptied and the bottle
rinsed several times. Then, after drying, the bottle must
be reweighed to obtain the sample weight. This process
takes one analyst approximately 30min per powdered
blend sample. Second, the large number of powdered
samples associated with a process validation (20-50 blend
samples) is extremely labour intensive and requires 10
man hours to prepare only 20 powdered samples. Third,
in the generic industry there is a high demand for
maximum throughput with minimum manpower. There-
fore the need was to increase the efficiency of the testing
of process validation samples and it was determined that
automation was the avenue to take to accomplish this
goal.
This presentation described the requirements of a system
to handle powdered process validation samples. The
benefits of an automated procedure as opposed to a
manual procedure were explained.
Experiences with fibre optic technology in auto-
matic dissolution testing
H. D. Friedel and D. Wortig
Bayer AG, Leverkusen, Germany
In recent years, dissolution testing has become increas-
ingly important in the development of new solid dosage
forms. Dissolution results also indicate batch homogene-
ity and conformity. Samples are generally removed from
the dissolution vessel through a filter at specified inter-
vals. The active ingredient content is determined by
HPLC or UV spectroscopy, both with manual sampling
and in automatic systems.
Precipitation or adsorption of the drug on the filters or
tubes may occur when the sample is taken. The amount
of released active ingredient is best determined in situ
directly in the vessel. The reading is taken very quickly,
enabling release kinetics from very quickly releasing
tablets to be recorded. A direct measurement is carried
out using a dipping probe connected via a fibre optic
cable to a UV/VIS spectrometer. The detector is inte-
grated into an automatic system. A robot, manufactured
by Zymark, moves on a linear axis and dips the measur-
ing probe in the solution at the times stipulated. The
system carries out dissolution tests fully automatically. All
steps are automated, from preparing the media, filling
the dissolution vessels and adding the tablet, to calibra-
tion, measuring, and cleaning the vessels. Robot systems
with fibre optic detection, which allow several tablet
batches to be analysed without supervision, have been
working in the authors’ laboratory since 1992.
A Q.A robotic system to perform chemical
analyses
Marie Sabo and Juan Cadavid
Clairol, Inc., Stamford, CT, USA
A robotic system has been designed for and implemented
in the chemical quality assurance laboratory, which
supports consumer product production operations. The
initial decision was made to automate chemical testing of
the largest volume manufactured products, both as in-
process and final package samples, which are in five
aluminium tubes. A proposal was presented for a Zymark
custom-designed Zymate robotic system capable of ad-
dressing the highest throughput analyses performed: two
titrations (acid-base type) and a viscosity measurement.
These titrations have historically been performed manu-
ally in QA, although Analytical had used Brinkmann
autotitrators for some time. Since the chemistry was well
known and the autotritrator methods had already proven
to be accurate and precise, these appeared to be ideal
analyses for robotic automation. The viscosity determina-
tions would not be as straightforward; since the samples
had only been prepared manually no automation had yet
been developed. It was felt that the sample preparation
could be automated with some effort, and in fact, would
probably be more reproducible than the manual proce-
dure. The actual viscosity measurement is made using a
Brookfield viscometer. The system would also need to
contain and dispense at least 10 different reagents and be
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able to move, manipulate, and clean-up materials with a
range of viscosities from water-thin to thick gels.
Although it would initially be used by QA analysts, the
system was designed with a non-scientist operator in
mind. The long-term goal is for a production worker to
be able to bring a sample to the robot, be computer
prompted through sample entry into the sytem, and some
time later receive an ’approved’ or ’not approved’ result.
(The latter situation would then require QA-human
intervention.) It was, therefore, necessary to develop a
database of all products, product specifications, test
methods, method parameters, variables, and calculations
for incorporation into the system. The user should only
need to know and enter two pieces ofinformation into the
system: a product number and whether the sample is in-
process or in a final package. The computer should tell
the operation exactly where to place the sample in the
system racks. The database would need to contain
information and specs for over 500 products to be
analysed using about 30 method variations.
The robotic system which meets these requirements was
presented and discussed. Recent enhancements made to
the original operation design, which have expanded the
use of the system, were also described.
It’s 1.00a.m.mdo you know how your robot is
performing?
j. R. Ormand
The Dow Chemical Company, Midland, MI, USA
For several years, the author’s laboratory has been
focusing on improving the efficiency of its work processes.
A key measurement is cycle-time for sample sets. Large
cycle-time reductions have been achieved through stan-
dardization of sample preparation, analysis, data reduc-
tion, report writing, and data review. Further reduction
ofsample set cycle-time has been investigated by examin-
ing the effectiveness of the automated systems.
This presentation described the performance of a Zymate
XP robot which has been used for the five years to
perform a complex liquid/solid extraction process. The
system’s performance has been studied for approximately
two years, focusing on the number ofsample preparations
that are completed without operator intervention. The
details of these measurements, comparisons to other
applications and systems, as well as the implementation
of process improvements were discussed.
Application of automated polymer analysis
Paul L. Morabito, John J. Zieman,
Ramasamy Tamilarasan, Ward L. Rigor
The Dow Chemical Company, Midland, MI, USA
Paul D. Hazelwood, Mark (]ranch and
Roger Gagnon
The Dow Chemical Company, Samia, Ontario, Canada
Over the past three years, laboratory robotic automation
efforts within Dow Chemical have been directed towards
developing systems to prepare a variety of different
polymer samples for subsequent analysis. These systems
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required development of custom hardware modules to
provide automation for both high and low temperature
dissolution techniques, for solution filtration and concen-
tration techniques, analytical instruments interfaces and
multi-method capabilities. Because of the complexity
associated with the polymer preparation and lack of
suitable on-line analysers, laboratory robotics were
chosen as the automation platforms. Recently, two
robotics automation systems were developed and in-
stalled in the high Density Polyethylene and Polystyrene
Samia production facilities. This presentation described
the technical merits of the hardware automation, as well
as the complex flexible operating protocols required to
rapidly support production.
The care and feeding of robot Jock
Norman E. Fraley, Jr.
Kelly Scientific Resources, Des Plaines, IL, USA
This presentation took a light-hearted look at the issues
involved with robots and personnel. The introduction of
the robot tends to generate the amazing transmogrifica-
tion of normal chemists into the robot Jock. This new
species of scientist has its own unique set of needs and
feeds. This creature was examined both in the wild and in
its natural habitat. Some of the fears and favours of this
entity were explained and ways to ensure that this rare,
and extremely valuable, creature is well cared for were
outlined.
Open access mass spectrometry in combinatorial
chemistry
Lester C. Taylor, Jeremy Batt, Robert L. Johnson
and Melanie Traynor
GlaxoWellcome, Research Triangle Park, NC, USA
The introduction of open access mass spectrometry has
significantly changed the way in which the synthetic
chemist undertakes routine sample analysis. The avail-
ability ofwalk-up instruments allows the chemist to carry
out sample analysis usually within a few minutes. As a
result, mass spectrometry is used routinely for reaction
monitoring, analysis of analytical and preparative HPLC
fractions, synthetic intermediates and final products. The
development of atmospheric pressure ionization (API)
has facilitated routine and reliable operation of such
general access instruments. This includes the use of
electrospray (ES) and atmospheric pressure chemical
ionization (APCI) sources which provide molecular
weight information (often with some degree of fragmen-
tation) for the vast majority of polar, thermally labile
molecules. However, there are compound classes (for
example, less polar, volatile compounds) which do not
give molecular weight information by API and for which
chemical ionization is a more appropriate ionization
mode. As a result the authors have also introduced an
Open Access GC-MS instrument for the analysis of such
compounds.
Combinatorial synthesis is being adopted as a routine
approach for the generation of large numbers of com-
pounds in the drug discovery process. This has placed an
increased burden on analytical methods to supportAbstracts of papers presented at the 1996 ISLAR
characterization and synthesis validation. A mass spec-
trometer has been acquired which utilizes a Gilson 215
autosampler directly sample 96-well microtiter plates at
the rate of approximately one sample per minute. This
system utilizes computer software to facilitate data analy-
sis and rapidly validate the chemistries for each plate.
Target compound molecular weights can be searched
and compared automatically to the data for each well
analysis, providing the chemistry with a quick evaluation
of library synthesis.
Adding value to enterprise-wide research and
development programs through automated NMR
spectroscopy
William C. Hutton
Corporate Research, Monsanto Company, St. Louis, MO, USA
NMR spectroscopy generates information vital to busi-
nesses who use chemistry and biology to invent and
develop new products. NMR spectroscopy is resource
intensive as well. Laboratory automation brings value by
maximizing the quantity and quality of NMR data
throughput and R&D enterprise. This paper presented
a unique robotics system used to collect NMR data. The
approach provides the efficiency of automated measure-
ment without sacrificing flexibility. The impact on the
NMR laboratory as well as the technical community
were addressed. The technical and cultural obstacles
encountered during this project were discussed. Informa-
tion technology is no less important than productive
measurement of spectra. An NMR information system
based on a UNIX/TCP-IP/X-Windows computer net-
work was presented.
Automation of structure analysis in pharmaceu-
tical R&D
Gary A. McClusky, Brian Tobias, Robert Short,
Dana E. Dejohn, Leslie McMacken,
Carmen Faraianu and Bryan Judge
Parke-David Pharmaceutical Research, Ann Arbor, MI, USA
The analytical chemistry laboratory in pharmaceutical
research continues to be challenged to perform structural
characterization rapidly and accurately. This is fuelled
by improvements in organic synthesis, such as automated
synthesis and combinatorial chemistry, and the avail-
ability of better structural tools and methods. Advances
in instrumentation, robotics and computer technology
have enabled automation of the associated tasks, such as
sample preparation, sample introduction, data acquisi-
tion and procession, and data storage and retrieval. The
integration of these components with laboratory informa-
tion systems results in improved overall efficiency of
laboratory operation. This, in turn, allows the laboratory
analyst to direct significant time to challenging structural
characterization projects and away from standard analy-
sis.
Laboratory robotics have been used to automate sample
preparation forNMR and MS analysis. Barcoded sample
vials are delivered to the robot and are prepared using
information obtained from the laboratory information
management system (LIMS). Modules associated with
this system include barcode reader, solvent dispensing
station, vortex mixer, pipetter, and turbidity check and
filtration stations. The dissolved sample solution is dis-
pensed into an NMR tube or MS vial, which is then
capped, and placed into an autosampler rack on the
respective spectrometer.
Some analysis is performed in a batch mode on auto-
mated NMR and mass spectrometers using instrument
worklists download from the LIMS. Data acquisition and
processing occur without analyst intervention. Data file
transfer and loading completed results into the LIMS are
triggered by the analyst.
Data files are archived on a file server equipped with an
optical jukebox and indexed in a relational database.
Data files are retrieved through querying the database
and transferring files back to a spectrometer. Information
system features include sample login front-end for custo-
mer use, e-mail notification of results, intranet access to
sample and instrument status, and results through Net-
scape. The careful integration of analytical instrumenta-
tion, robotics and information systems results in an
efficiently operating laboratory that can meet the ever
increasing demands of a research environment.
High throughput cell based assay robotics system
with integrated diagnostics and data management
Steven Lenz, Ed Marples and Mel Reichman
Ligand Pharmaceuticals Inc., San Diego, CA, USA
Cell based assays are performed in a high throughput
mode for drug screening at Ligand. A robotics system for
automatically performing these assays in the evening,
and functional as a series of independent workstations
for use during the day, was built and implemented. The
system integrates a 96-well pipettor, plate washer, re-
agent addition station, luminometer and a tissue culture
incubator with a CRS Robotics A265 arm and flexible
data management software by MLR Automation. The
96-well pipettor is a Robbin’s Hydra that was modified
with a wash station and plate shuttling device. It is used
to pipette gl of compound directly into the assay plates
at better than 7% CV. The incubator was modified with
miniature pneumatically actuated doors and rotating 120
plate carousel. These modifications and the slowly rotat-
ing carousel, minimize environmental disturbances and
edge effects caused by the robot accessing the incubator.
Reagents, compound and assay plates are barcoded with
unique identifiers. This information is read by the robot
and written into the data file headers. MLR Automa-
tion’s CSAP software has been modified to interface with
Oracle. It automatically processes and uploads the data
based on the file headers. CSAP then generates a list of
retests to be submitted to the compound handling system.
A vision system and modem have been integrated into
the system’s computer. This allows the robot or an
operator to transmit still photos of the robot when the
system halts due to an error. The operator may then
remotely diagnose the problem and attempt corrective
action.
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High-throughput screening by remote control
Junko Aimi and Michael R. Kozlowski
Geron Corporation., Menlo Park, CA, USA
Laboratory automation is an essential component of the
high-throughput screening laboratory. The robotics sys-
tems are used to perform repetitive functions and free
humans for more creative activities. Major limitations of
automated systems are: errors occur during the course of
a large run; software programs available for performing
high-throughput screens are not flexible enough to
accommodate special needs within an assay; and changes
need to be implemented in a timely manner.
This presentation discussed approaches designed for
monitoring automated screens and for performing real-
time modifications of protocols and error corrections.
This included a simple baby-sitting program that con-
tacts individuals when an interruption in an automated
run is detected; a video monitoring system that allows an
individual to survey multiple systems and/or supervise
robotics operations from a remote location; and an
interactive system (under development) which allows
monitoring of robot modules and error corrections in
real-time.
Automated systems for dilute solution viscosity
measurement of polymers using a Zymate Robot
and a Viscotek Differential Viscometer
Sador S. Black, Tab Crawford and Harold Kinder
Eastman Chemical Company, Kingsport, TN, USA
Solution viscosity analysis is a fast, simple, and reliable
method for determining the molecular weight of a
polymer. The polymer molecular weight is an important
property since it reflects the ability of the polymer to be
processed and the polymer’s fitness for use in various
applications. In the Polymers Division of Eastman
Chemical Company, the Analytical Services Laboratory
is responsible for determining the Inherent Viscosity (IV)
of all production process samples. IV determination can
be broken down into several steps: sample preparation;
sample analysis; sample cleanup; and data reporting.
Each of these steps was previously performed by labora-
tory analysts in the Analytical Services lab. The motiva-
tion to automate IV testing came from several sources.
The first incentive was an increasing sample load. It was
believed that automation, coupled with the use of
different viscometers, could increase laboratory sample
capacity. Safety was another incentive. The solvent
which is used to dissolve the polymer sample is very
hazardous. Automation was expected to greatly reduce
the analysts’ exposure to the solvent. There was also an
economic incentive. Two analysts were required to per-
form the manual IV test. It was felt that automation of
the system would reduce this number to one and free the
second analyst to perform other jobs.
The process of transferring the manual operation to an
automated one required hardware and software integra-
tion between the Zymate robot, the PC used to control
the differential viscometer, the LIMS computer in the
Analytical Services Lab and the Polymers Manufactur-
ing Information System (a VAX computer which main-
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tains all production data). The integration process
required many trials, and custom equipment was needed
for several robot functions. The current system consists of
two Zymate XP robots performing solution viscosity
analysis on a 24 hour basis, 365 days per year.
To buy or not to buy? Peripherals from robot
suppliers
Michael R. Kozlowski
Geron Corporation, Menlo Park, CA, USA
High-throughput screening groups are frequently faced
with difficult decisions concerning the most effective ways
of automating drug discovery processes. These decisions
generally do not involve which robotic arm to use, since
the number of choices in this area is still relatively small,
but the type ofinstruments that the robotic arm will serve
(peripherals). There are two broad types of robot per-
ipherals. The first are stand alone instruments--these are
often automated but are not integrated with a robotic
arm. The integration is left as an exercise for the
purchases. The second class is integrated instruments.
These are designed to be used with a robotic arm (often
exclusively) and are available from suppliers of robotic
arms as modules or as part ofa turn-key robotic platform.
Each of these types of peripherals has its strengths and
weaknesses, some of which are related to the type of task
being performed, as well as the laboratory environment.
Because of the time and expense involved in setting up a
robotic screening laboratory, an incorrect choice of robot
peripherals can cause, for the laboratory manager, con-
siderable loss of efficiency, face, and often another
anatomical feature. This paper discussed options in
choosing robot peripherals, and how to select the correct
instruments.
Robotic control of whole blood processing in a
clinical laboratory for functional brain imaging
David L. Alexoff, Payton King and S. John Gatley
Brookhaven National Laboratory, Upton, NY, USA
Clinical and basic research protocols using functional
imaging techniques like Positron Emission Tomography
(PET) or Single Photon Emission Tomography (SPET)
often require a significant personnel commitment to the
sampling and processing of whole blood samples from
human and non-human primate subjects. Blood gas,
plasma glucose, and radioactivity concentrations must
be determined for each imaging study. Faced with de-
creasing research operating budgets and the anticipated
addition of a second tomograph, the authors’ labor-
atory has begun investigating the utility of using labora-
tory robots to carry out some of these routine clinical
laboratory tasks necessary for clinical and basic research
protocols using PET.
This presentation described the routine clinical labora-
tory tasks needed in PET research and how these tasks
have been automated using a commercially available
laboratory robot system. The system is based on standard
components of Zymark Corporation’s (Hopkinton, MA,
USA) PyTechnology systems. No custom robot hardware
was used, and all software was developed at BrookhavenAbstracts of papers presented at the 1996 ISLAR
National Laboratory. An algorithmic approach to sol-
ving the problem of pipetting plasma from small-volume
whole blood samples (< 0"04ml) was described. The
system automatically centrifuges small-volume whole
blood samples, pipettes and weighs plasma, and assays
511 KeV photon radioactivity in the plasma. Steady state
robotic throughput is 143 samples/hour for auto-sampled
whole blood. Results and performance of the robotic
system were compared with those obtained manually
by an experienced laboratory technician.
This research was carried out at Brookhaven National
laboratory under contract DE-AC02-76CH00016 with
the US Department of Energy and supported by its
Office of Health and Environmental Research and also
supported by the National Institutes ofHealth Grant NS-
15380.
It’s only a matter of time
F. H. Zenie
Zymark Corporation, Hopkinton, MA, USA
Columbus set out for China and discovered America.
Was the journey a success or failure? It has to be a failure
unless you redefine the goals. We are surrounded by
opportunities, the challenge is recognizing them and then
redefining our goals to capitalize on the new opportunity.
Changing markets and economics demand business in-
novation. We are learning that new technologies enable
change, but management must lead business innovation.
Today’s managers must shift from directing work to
translating business strategies into action plans and
energizing people to implement the plans. Simplistic
accounting measurements are being replaced by business
impact analysis, and judgment.
Over the past 15 years, laboratory automation has grown
from a novel new technology to a powerful management
tool to help leading organizations become more innova-
tive, productive and competitive. The greatest value
comes from applying automation in the context of
business strategies. Those who excel will gain competitive
advantage, grow and prosper.
The use of robotics in a cosmetic microbiology
laboratory
Steven F. Schnittger
Estee Lauder Companies, Melville, NY, USA
The preservative challenge test is a method used to
determine the efficacy of a preservation system in a
cosmetic formulation. The method of testing is a labour
intensive, repetitive task. Product testing entails a large
volume of samples which are analysed repeatedly under
the same conditions and protocol. For this reason, an
automated robotic system was developed to perform this
testing and to free the cosmetic microbiologist to perform
more meaningful and creative tasks.
Two hundred and fourteen different formulations totall-
ing 1039 samples were evaluated, comparing the auto-
mated robotic system to the manual plate count method
of testing. The samples comprised make-ups, shampoos,
conditioners, oil in water emulsions, mascaras and pow-
ders. The selection of micro-organisms tested are similar
to those recommended by the CTFA Guideline for the
Preservation Testing of Eye Area Products.
The results showed that there was a greater than 98%
correlation in results when comparing the automated
plating system to the manual method of testing. It has
also been determined that the robot can save between
two to three man hours per day.
The unattended sample preparation of the robot, allows
for testing to continue beyond the normal work day of the
job. By programming the robot to run 24 hours per day,
the microbiologist or technician is able to perform other
functions in the lab. It also allows for an increase in the
workload of the lab, improving the throughput of the lab,
without additional personel.
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